US20110177551A1 - Method for producing a chemical product and continuous fermentation apparatus - Google Patents

Method for producing a chemical product and continuous fermentation apparatus Download PDF

Info

Publication number
US20110177551A1
US20110177551A1 US13/121,727 US200913121727A US2011177551A1 US 20110177551 A1 US20110177551 A1 US 20110177551A1 US 200913121727 A US200913121727 A US 200913121727A US 2011177551 A1 US2011177551 A1 US 2011177551A1
Authority
US
United States
Prior art keywords
culture liquid
culture
liquid
membrane
membrane separation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/121,727
Other languages
English (en)
Inventor
Takashi Mimitsuka
Kentaro Ishii
Ken Morita
Masashi Higasa
Kenji Sawai
Hideki Sawai
Katsushige Yamada
Shinichi Minegishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Assigned to TORAY INDUSTRIES, INC. reassignment TORAY INDUSTRIES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HIGASA, MASASHI, ISHII, KENTARO, MIMITSUKA, TAKASHI, MINEGISHI, SHINICHI, MORITA, KEN, SAWAI, HIDEKI, SAWAI, KENJI, YAMADA, KATSUSHIGE
Publication of US20110177551A1 publication Critical patent/US20110177551A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/56—Lactic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C12M1/12—Apparatus for enzymology or microbiology with sterilisation, filtration or dialysis means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/18—External loop; Means for reintroduction of fermented biomass or liquid percolate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/06—Tissue, human, animal or plant cell, or virus culture apparatus with filtration, ultrafiltration, inverse osmosis or dialysis means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/10—Separation or concentration of fermentation products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/001—Amines; Imines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids

Definitions

  • the present invention relates to a method for producing a chemical product by utilizing culture of microorganisms or culture cells. More specifically, the present invention concerns a method for producing a chemical product and a fermentation apparatus in which, while carrying out culture, a liquid containing a fermentation product (chemical product) produced by the culture is efficiently filtered from a culture liquid containing microorganisms or culture cells through a separation membrane to collect the fermentation product, so that a desired chemical product can be produced with high productivity.
  • the material producing method relating to the culture of microorganisms or culture cells is mainly classified into (1) Batch culture method and Fed-Batch culture method, as well as (2) continuous fermentation method.
  • the continuous fermentation method of the above-mentioned (2) is characterized in that, by avoiding the fermentation product in a fermentation tank from accumulating with a high concentration, the productivity and yield can be maintained in a high level for a long time.
  • a continuous fermentation method has been disclosed with respect to the fermentation of L-glutamic acid (see Patent Document 1) and L-lysine (see Non-Patent Document 1).
  • materials such as nutrients
  • the culture liquid containing microorganisms or culture cells is also drawn, with the result that the microorganisms or culture cells in the culture liquid are diluted; therefore, the improvement of its production efficiency is limited.
  • a technique has been proposed in which continuous fermentation is carried out by using a continuous fermentation apparatus with a separation membrane (see Patent Document 2).
  • a continuous fermentation apparatus provided with a tank used for cultivating microorganisms or culture cells and a tank used for membrane separation on a target fermentation product from the microorganisms and culture cells in the culture liquid, is used so that various chemical products can be produced at a higher production speed in comparison with the batch culture method and with the fed-batch culture method.
  • the flow velocity of the culture liquid inside a liquid transfer line is decreased and the microorganisms or culture cells are precipitated inside the liquid transfer line, and a problem of decreasing of the production efficiency occurs.
  • the pressure inside the membrane separation tank is too high, the microorganisms in the culture liquid transferred outside from the membrane separation tank might be damaged due to pressure fluctuation.
  • an object of the present invention is to provide a method for producing a chemical product, which can control flow velocity of a culture liquid inside a membrane separation tank without giving influences to culture conditions in the fermentation tank, and also suppress precipitation of microorganisms or culture cells so that the production efficiency of the chemical product can be improved, as well as a fermentation apparatus to which such a method can be desirably applied.
  • the inventors of the present invention have made extensive studies on a continuous fermentation apparatus utilizing a separation membrane in order to improve a producing speed and stabilize fermentation culture, and as a result, the inventors have found that by using any of the following structures (1) to (14), it is possible to properly maintain culture conditions (retention time of the culture liquid and so on), while controlling the flow velocity of culture liquid inside a membrane separation tank, and consequently to efficiently produce a chemical product, and have completed the present invention.
  • one portion of the culture liquid to be transferred from the fermentation tank is allowed to bypass the membrane separation tank depending on a pressure at the culture liquid flow-in side of the membrane separation tank, that is, the flowing quantity of the culture liquid to be supplied to the membrane separation tank and the flowing quantity of the culture liquid to be transferred from the fermentation tank can be controlled independently.
  • the flowing quantity of the culture liquid to be supplied to the membrane separation tank and the flowing quantity of the culture liquid to be transferred from the fermentation tank can be controlled independently.
  • the present invention by controlling the recovery percentage of the filtration liquid in the membrane separation tank to 10% or less, with one portion of the culture liquid to be transferred from the fermentation tank being allowed to bypass the membrane separation tank depending on the pressure at the culture liquid flow-in side of the membrane separation tank, it becomes possible to further prevent fouling of the membrane and to prolong a continuous fermentation time.
  • the production efficiency and sugar-related yield of a fermentation product obtained by continuous fermentation can be simultaneously improved, and by further controlling the recovery percentage in the membrane separation tank to 10% or less, the continuous fermentation time can be also prolonged.
  • FIG. 1 is an outline schematic view that explains one embodiment of a continuous fermentation apparatus in accordance with the present invention.
  • FIG. 2 is an outline schematic view that explains another embodiment of the continuous fermentation apparatus in accordance with the present invention.
  • FIG. 3 is a schematic development that explains one embodiment of a separation membrane element used in the present invention.
  • FIG. 4 is a schematic perspective view that explains another embodiment of the separation membrane element used in the present invention.
  • FIG. 5 is a drawing that illustrates a physical map of a yeast expression vector pTRS11 used in a reference example.
  • FIG. 6 is a drawing that shows a linear flow velocity of culture liquid inside a circulation line and an amount of bacteria precipitated inside the line, obtained in example 2.
  • FIG. 7 is an outline schematic view that explains still another embodiment of the continuous fermentation apparatus in accordance with the present invention.
  • FIG. 8 is an outline schematic view that explains still another embodiment of the continuous fermentation apparatus in accordance with the present invention.
  • FIG. 9 is an outline schematic view that explains a mode of a continuous fermentation apparatus used in comparative examples.
  • FIG. 10 is a drawing that shows a lactic acid concentration and a yeast turbidity obtained in example 1.
  • FIG. 11 is a drawing that shows a lactic acid concentration and a yeast turbidity obtained in comparative example 1.
  • FIG. 12 is a drawing that shows a pressure of a culture liquid at the flow-in side of a membrane separation tank, obtained in comparative example 1.
  • FIG. 13 is an outline schematic view that explains a mode of a continuous fermentation apparatus used in the comparative example.
  • FIG. 14 is an outline schematic view that explains still another embodiment of the continuous fermentation apparatus in accordance with the present invention.
  • FIG. 15 is an outline schematic view that explains a mode of a continuous fermentation apparatus used in the comparative examples.
  • FIG. 16 is an outline schematic view that explains the other embodiment of the continuous fermentation apparatus in accordance with the present invention.
  • FIG. 17 is a drawing that shows a transition of transmembrane pressure differences obtained in examples 6 to 9.
  • FIG. 18 is a drawing that shows a cadaverine concentration and a coryneform-bacteria turbidity obtained in example 10.
  • FIG. 19 is a drawing that shows a cadaverine concentration and a coryneform-bacteria turbidity obtained in comparative example 5.
  • FIG. 20 is a drawing that shows a pressure of a culture liquid at the flow-in side of a membrane separation tank obtained in comparative example 5.
  • FIG. 21 is a drawing that shows an L-lysine concentration and a coryneform-bacteria turbidity obtained in example 11.
  • FIG. 22 is a drawing that shows an L-lysine concentration and a coryneform-bacteria turbidity obtained in comparative example 6.
  • FIG. 23 is a drawing that shows a pressure of a culture liquid at the flow-in side of a membrane separation tank obtained in comparative example 6.
  • a method of the present invention relates to a method for producing a chemical product, in which microorganisms or culture cells are cultivated in a fermentation tank, and the culture liquid is continuously transferred from the fermentation tank to a membrane separation tank so as to be filtered through a separation membrane so that a fermentation product is collected from the filtration liquid as a chemical product, while an unfiltered culture liquid that has not been filtered is refluxed so as to be joined to the culture liquid on an upstream side from the membrane separation tank, and at this time, one portion of the culture liquid transferred from the fermentation tank is allowed to bypass the membrane separation tank in response to a pressure of the culture liquid at the flow-in side of the membrane separation tank.
  • FIG. 1 is an outline schematic view showing a fermentation apparatus in accordance with one embodiment of the present invention.
  • the fermentation apparatus shown in FIG. 1 is constituted by a fermentation tank 1 in which microorganisms or culture cells are cultivated, and a membrane separation tank 2 provided with a separation membrane 3 used for filtering the culture liquid.
  • the membrane separation tank 2 is installed outside a fermentation reaction tank, and connected to the fermentation tank 1 through a liquid transfer line 17 and a liquid transfer line 15 (circulation line).
  • the fermentation tank 1 has a function for continuously cultivating microorganisms or culture cells, and any tank may be used as this, as long as the circulation line can be connected to the tank; thus, a jar fermentor or the like, which has been conventionally used for cultivating microorganisms or culture cells, may be utilized.
  • the fermentation tank 1 which is connected to a medium supply pump 6 , is provided with a stirrer 7 so that a medium is loaded into the fermentation tank 1 by the medium supply pump 6 , and, if necessary, allows the stirrer 7 to stir the culture liquid inside the fermentation tank 1 .
  • a gas-supply device 8 is also connected to this so that, if necessary, a required gas is supplied by the gas-supply device 8 .
  • a pipe is preferably located between a head space of the fermentation tank 1 and the gas-supply device 8 so that, by allowing the supply gas to flow in the order of the head space, the pipe and the gas-supply device 8 , recovery and recycle may be preferably carried out.
  • a pH sensor-control device 9 and a pH adjusting solution supply pump 10 are attached to the fermentation tank 1 , if necessary, so as to adjust the pH of the culture liquid.
  • a plurality of pH adjusting solution supply pumps are preferably used.
  • a temperature adjuster 11 is also attached thereto so as to adjust the temperature of the culture liquid to produce a chemical product with high productivity.
  • the adjustments of the physiochemical conditions of the culture liquid by measuring and controlling devices have been exemplified; however, if necessary, controlling processes may be carried out on dissolved oxygen and ORP, and the concentration of microorganisms in the culture liquid may be further measured by an analyzer, such as an on-line chemical sensor, so that based on the resulting index, the physiochemical conditions may be controlled.
  • an analyzer such as an on-line chemical sensor
  • the load amount of medium and the speed thereof can be adjusted on demand.
  • a separation membrane 3 may be installed inside the membrane separation tank 2 , and in the same manner as the fermentation tank 1 , the shape and the like of the membrane separation tank 2 are not limited as long as a circulation line can be connected thereto.
  • any separation membranes may be used as long as only the microorganisms or culture cells can be filtered off from the culture liquid containing the microorganisms or culture cells; however, a porous membrane having appropriate separation and permeation performances in accordance with properties of the liquid to be processed and applications, which will be described later, is preferably used, and the membrane is preferably provided with resistance to sterilization (for example, at 120° C. for 30 minutes).
  • the separation membrane 3 is connected to a pump 4 so as to generate a transmembrane pressure difference between the raw liquid side and the permeation side of the separation membrane.
  • the membrane separation tank 2 and fermentation tank 1 are preferably designed to have such volumes as to set a culture liquid volume ratio of the culture liquid in the fermentation tank to the culture liquid in the membrane separation tank to 4 or more to 100 or less. That is, by taking it into consideration that in general, the culture liquid having about 80% of the volume of each of the membrane separation tank 2 and the fermentation tank 1 is stored therein, the tanks are desirably designed so as to set the ratio of the volume of the fermentation tank to the volume of the membrane separation tank to 4 or more to 100 or less.
  • a bypass line 26 which is connected to the membrane separation tank on its culture liquid flow-out side by bypassing the membrane separation tank from the culture liquid flow-in side of the membrane separation tank 2 , is installed in the circulation lines (liquid transfer line 17 and liquid transfer line 15 ) so that, without supplying one portion of the culture liquid transferred from the fermentation tank 1 to the membrane separation tank 2 , the portion of the culture liquid can be joined to the unfiltered culture liquid of the liquid transfer line 15 , by bypassing the membrane separation tank 2 .
  • one end of the bypass line 26 is connected to the liquid transfer line 17 , with the other end being connected to the liquid transfer line 15 ; however, another structure in which the bypass line 26 is connected to the fermentation tank 1 by bypassing the membrane separation tank 2 from the culture liquid flow-in side of the membrane separation tank 2 , or is connected to a portion between the fermentation tank 1 and the culture liquid flow-in side of the membrane separation tank 2 . That is, one end (upstream side) of the bypass line 26 may be connected to the liquid transfer line 17 , with the other end (downstream side) being connected to the fermentation tank 1 , so as to directly reflux the one portion of the culture liquid that has bypassed the membrane separation tank 2 to the fermentation tank 1 .
  • bypass line 26 may be connected to the liquid transfer line 17 so as to allow the one portion of the culture liquid that has bypassed the membrane separation tank 2 to be directly joined to the culture liquid in the liquid transfer line 17 to be supplied from the fermentation tank 1 .
  • a flowing quantity control means 25 is installed in the bypass line 26 of the membrane separation tank 2 .
  • the flowing quantity of the culture liquid to be supplied to the membrane separation tank 2 can be controlled by this flowing quantity control means.
  • the flowing quantity control means may be prepared as either a valve or a pump, and from the viewpoint of costs, a valve is preferably used.
  • a valve is selected as the flowing quantity control means, the amount of the culture liquid to be supplied to the membrane separation tank 2 can be reduced by opening the valve.
  • by closing the valve all the culture liquid flowing through the liquid transfer line 17 is allowed to flow into the membrane separation tank 2 .
  • the structure of the valve is not particularly limited, a diaphragm valve or a butterfly valve is preferably used because, upon steam sterilization, the culture liquid or the like is hardly remained because of its structure.
  • a liquid transferring process can be carried out so as to allow the culture liquid to flow in the same direction as that of the culture liquid flowing through the membrane separation tank 2 so that by increasing the amount of the liquid transfer of the pump, the amount of the culture liquid to be supplied to the membrane separation tank 2 can be reduced, while, in contrast, by stopping the liquid transfer of the pump, all the culture liquid flowing through the liquid transfer line 17 is allowed to flow into the membrane separation tank 2 .
  • the flowing quantity of the culture liquid to be supplied to the membrane separation tank 2 is basically controlled depending on a pressure at the culture liquid flow-in side of the membrane separation tank.
  • a pressure meter 29 is installed in the apparatus as shown in FIG. 1 .
  • the pressure at the culture liquid flow-in side of the membrane separation tank is measured by the pressure meter 29 , and in the case where the measured value is higher than a desired value, by activating the flowing quantity control means 25 so that one portion of the culture liquid transferred from the fermentation tank 1 is allowed to bypass the membrane separation tank 2 , and circulated.
  • a pump 5 which controls the flowing quantity of the culture liquid to be transferred from the fermentation tank, is installed in the circulation line.
  • the pump may be installed in the liquid transfer line 17 or the liquid transfer line 15 (return path into the fermentation tank), and may also be installed in both of the lines.
  • the system, shape and the material for a liquid contact portion thereof are not particularly limited, those pumps that are resistant to steam sterilization in the circulation line are preferably used.
  • FIG. 6 shows a relationship between a culture liquid linear speed in the circulation line and an amount of precipitation of yeast strains having a lactic acid producing ability, and base upon these, it is found that in the case where the culture liquid linear speed in the circulation line (liquid transfer line 17 and liquid transfer line 15 ) is 2.5 cm/sec or more, the culture liquid can be circulated without allowing bacteria to be precipitated inside the pipe. Therefore, by detecting the linear flow velocity of the culture liquid inside the liquid transfer line 17 transferred from the fermentation tank and/or the unfiltered culture liquid inside the liquid transfer line 15 , the flowing quantity control means 25 and the pump 5 are preferably operated so as to set the linear speed to 2.5 cm/sec or more. Moreover, because of the same reason, the linear speed of the culture liquid in the bypass line 26 is preferably set to 2.5 cm/sec or more.
  • the flowing quantity control means 25 and the pump 5 can be operated so as to set the linear speed to 2.5 cm/sec or more.
  • the linear speed of the culture liquid is preferably set to 2.5 cm/sec or more in each of the two lines.
  • each of the linear speed of the culture liquid to be transferred from the fermentation tank to the membrane separation tank, the linear speed of the unfiltered culture liquid to be refluxed from the membrane separation tank so as to be joined to the culture liquid on the upstream side from the membrane separation tank and the linear speed of the culture liquid to be allowed to bypass the membrane separation tank is preferably set to 2.5 cm/sec or more.
  • a level sensor 12 is installed in the fermentation tank 1 .
  • the medium supply pump 6 can be controlled.
  • the amount of filtration liquid may be controlled.
  • the method for controlling the amount of the filtration liquid is not particularly limited, for example, a liquid-level pressure difference controlling device that alters the flowing quantity of the filtration liquid by controlling the liquid-level pressure difference may be installed, or the flowing quantity of the filtration liquid may be altered by driving a pump by using power of a power supply.
  • the fermentation apparatus to be used for producing a chemical product of the present invention is preferably provided with a steam supply line used for sterilizing a fermentation tank 1 , a membrane separation tank 2 and the liquid transfer lines 15 and 17 .
  • various pumps such as a centrifugal pump, a tube pump and a diaphragm pump
  • those pumps in which the amount of circulation liquid and the amount of filtration liquid from the separation membrane can be calculated based upon the output settings of the pump may be preferably used, and more specifically, a diaphragm pump and a tube pump are desirably used.
  • the culture is carried out, for example, in the following manner.
  • microorganisms or culture cells are continuously cultivated in the fermentation tank 1 , and the culture liquid is supplied to the membrane separation tank 2 from the fermentation tank 1 through the liquid transfer line 17 by the pump 5 inside the circulation line, and by causing a pressure difference between the raw liquid side and the filtration liquid side of the separation membrane 3 by a pump 4 or the like, the culture liquid is filtered so that a filtration liquid containing lactic acid or the like (chemical product) that is a fermentation product by the microorganisms or culture cells can be collected.
  • an unfiltered culture liquid is refluxed into the fermentation tank 1 through the liquid transfer line 15 .
  • the flowing quantity of the pump 5 is set to such a velocity (for example, 2.5 cm/sec or more in linear flow velocity, as described earlier) as to prevent the microorganisms or culture cells from precipitating in the liquid transfer line 17 and the liquid transfer line 15 .
  • the pressure inside the membrane separation tank is increased.
  • the pressure inside the membrane separation tank is preferably set to 1 MPa or less.
  • one portion of the culture liquid to be transferred from the fermentation tank 1 is allowed to bypass the membrane separation tank 2 and refluxed, in response to a pressure of the culture liquid at the flow-in side of the membrane separation tank 2 .
  • the flowing quantity of the culture liquid to be allowed to bypass the membrane separation tank 2 is controlled so as to set the pressure of the culture liquid at the flow-in side of the membrane separation tank to 1 MPa or less.
  • the pressure mentioned in this case, refers to a gauge pressure, and in the present invention, the pressure means a gauge pressure, unless otherwise specified.
  • the pressure fluctuations inside the membrane separation tank can be measured by the pressure meter 29 installed on the culture liquid supply side, and based upon the results of measurements, the flowing quantity of the culture liquid to be allowed to bypass the membrane separation tank is controlled so that the pressure increase inside the membrane separation tank can be controlled.
  • the producing speed of the fermentation product can be increased so that a very efficient fermentation production is achieved, with the fermentation product being efficiently recovered.
  • the production speed in the continuous culture can be calculated by the following equation (1):
  • a fermentation producing speed in a batch culture is found by dividing an amount of product (g) at the time when all the material carbon source has been consumed by a time (h) required for the consumption of the carbon source and the amount of culture liquid at that time (L).
  • the apparatus shown in FIG. 1 may be preferably revised, for example, in the following manner. That is, for example, as shown in FIG. 2 , the flowing quantity control means 25 may be preferably designed to be operated in response to the results of measurements of the pressure meter 29 . Moreover, a membrane separation tank open/close valve 27 may be preferably placed in the liquid transfer line 17 on the downstream side from the connected point to the bypass line 26 , at a position on the upstream side from the membrane separation tank 2 , or a membrane separation tank open/close valve 28 may be preferably placed in the liquid transfer line 15 on the upstream side from the connected point to the bypass line 26 , at a position on the downstream side from the membrane separation tank 2 .
  • an unfiltered culture liquid of the liquid transfer line 15 is preferably refluxed so as to be joined to the culture liquid inside the fermentation tank, and is also preferably refluxed so as to be directly joined to one portion of the culture liquid of the liquid transfer line 17 .
  • the pump 5 which controls the flow velocity and flowing quantity of the unfiltered culture liquid to be refluxed so as to be joined to the culture liquid inside the fermentation tank, and also controls the flow velocity and flowing quantity of the culture liquid to be transferred from the fermentation tank, is placed at the downstream side closer to the fermentation tank of a branch point 14 B in the liquid transfer line 15 ; and in a separate manner from this, a pump 16 is also placed at the downstream side of a joining point 14 A in the liquid transfer line 17 .
  • circulation circuits which are independent from the fermentation tank 1 , are formed with the downstream side of the joining point 14 A in the liquid transfer line 17 and the membrane separation tank 2 , as well as with the upstream side of the branch point 14 B in the liquid transfer line 15 .
  • the pumps 16 and 5 are each allowed to control the flow velocity and flowing quantity of the circulation circuit formed with the downstream side of the joining point 14 A in the liquid transfer line 17 and the membrane separation tank 2 , as well as with the upstream side of the branch point 14 B in the liquid transfer line 15 , and the flow velocity and flowing quantity of the circulation circuit formed with the downstream side of the branch point 14 B in the liquid transfer line 15 and the fermentation tank 1 , as well as with the upstream side of the joining point 14 A in the liquid transfer line 17 , in an each independent manner.
  • the flow velocity of the culture liquid inside the circulation circuit is increased by adjusting the pump 16 , that is, even when the linear speed (linear flow velocity) of the culture liquid flowing on the surface of the separation membrane 3 inside the membrane separation tank is increased, the flow velocity at the downstream side of the branch point 14 B in the liquid transfer line 15 can be maintained in a constant level by the pump 5 so that the velocity of the culture liquid returning into the fermentation tank 1 is maintained in a constant level.
  • the flowing quantity or flow velocity of the unfiltered culture liquid to be refluxed so as to be joined to the culture liquid in the fermentation tank (that is, the flowing quantity or flow velocity at the downstream side of the branch point 14 B in the liquid transfer line 15 )
  • ⁇ is preferably set to be smaller than the flowing quantity or flow velocity of the unfiltered culture liquid to be refluxed so as to be joined to the culture liquid between the fermentation tank and the membrane separation tank (that is, the flowing quantity or flow velocity at the downstream side of the branch point 14 A in the liquid transfer line 17 ) ⁇
  • the ratio of these ⁇ / ⁇ is preferably set to 1 or less.
  • the liquid transfer line 15 used for refluxing the unfiltered culture liquid so as to be joined to the culture liquid inside the fermentation tank is preferably designed to have an opening at a position that is immersed in the culture liquid stored in the fermentation tank 1 .
  • the oxygen transfer coefficient kLa inside the fermentation tank 1 is made to be hardly fluctuated from a desired set value, so that the reduction rate of the coefficient from the set value can be suppressed within 30% of the set value.
  • a plurality of membrane separation tanks 2 are preferably connected in parallel with one another.
  • the membrane separation tanks can be switched and properly used so that the culture can be continued without stopping the filtration inside the membrane separation tank.
  • sterilization can be carried out in each of the membrane separation tanks individually.
  • a recovery percentage that is a rate of the flowing quantity of the filtration liquid obtained from the separation membrane 3 relative to the flowing quantity of the culture liquid to be transferred to the membrane separation tank (hereinafter, sometimes, referred to simply as “recovery percentage”) is preferably controlled to be 10.0% or less.
  • the recovery percentage refers to a ratio of the amount of filtration liquid from the separation membrane 3 to the amount of culture liquid (amount of circulated liquid) that has been transferred to the membrane separation tank per unit time, and is calculated by the following (equation 2).
  • the amount of filtration liquid can be replaced by the separation membrane area used in the membrane separation tanks and the flux that can be drive-controlled so that (equation 2) can be converted into the following (equation 3).
  • the amount of culture liquid to flow into the membrane separation tank and/or the amount of filtration liquid from the separation membrane can be adjusted. That is, one or more factors, selected from the amount of circulated liquid, flux and amount of filtration liquid, are preferably controlled.
  • outputs of the pumps 5 and 16 located at the upstream side of the membrane separation tank, as described earlier, are preferably adjusted.
  • the output adjustment of the pump 4 is preferably carried out.
  • flow meters are installed in the liquid transfer line 17 and a filtration liquid draw-out line of the separation membrane 3 , and by regularly monitoring the amount of circulated liquid and the amount of filtration liquid, the recovery percentage is calculated from (equation 2) so that the pumps 4 and 5 are preferably driven, while the outputs thereof are being controlled so as to set the recovery percentage to 10.0% or less.
  • a driving operation so as to control only the flux, with the amount of circulated liquid being maintained in a constant level can be carried out.
  • a driving operation so as to control the amount of circulated liquid, with the flux being maintained in a constant level can also be carried out.
  • the recovery percentage is preferably controlled so as to be set to 5.0% or less. From the viewpoint of enhancing the energy efficiency, the recovery percentage is set as high as possible. Therefore, the lower limit of the recovery percentage is preferably set to at least 0.01% or more.
  • the flux can be calculated from the following (equation 4).
  • Flux Amount ⁇ ⁇ of ⁇ ⁇ filtration ⁇ ⁇ ⁇ liquid ⁇ ⁇ ( m 3 / day ) Area ⁇ ⁇ of ⁇ ⁇ separation ⁇ ⁇ membrane ⁇ ⁇ ( m 2 ) ( Equation ⁇ ⁇ 4 )
  • the membrane area used in the apparatus can be desirably set.
  • the volume (m 3 /day) of filtration liquid amount is preferably obtained by measuring the volume of filtration liquid amount in one day; however, the volume of filtration liquid per day may be schematically calculated by measuring the volume of the amount of filtration liquid for about one hour.
  • the flux is preferably set to 0.500 m/day or less, more preferably, in a range from 0.050 m/day or more to 0.400 m/day or less. In the case where the flux exceeds 0.500 m/day, it sometimes becomes difficult to maintain continuous culture by controlling the recovery percentage. Moreover, in the case where the flux is less than 0.050 m/day, this fact means that the area of the separation membrane is too large, making it difficult to put into industrial use, from the economic viewpoint.
  • a microorganism and a culture raw material are stored in the fermentation tank 1 , and by adding a neutralizer thereto on demand, the inside of the fermentation tank 1 is maintained in a range from pH 4 to 8, with a temperature thereof being maintained in a range from 20 to 50° C.
  • desired fermentation products chemical products
  • desired fermentation products such as alcohol, an organic acid, an amino acid, a nucleic acid, and the like.
  • the culture liquid inside the fermentation tank 1 is continuously circulated between the fermentation tank 1 and the membrane separation tank 2 so as to set a linear flow velocity inside a circulation line to 2.5 cm/sec or more by the pump 5 .
  • the culture liquid is filtered and separated into an unfiltered culture liquid containing the microorganisms and a filtration liquid containing fermentation products by using a separation membrane.
  • the filtration liquid containing fermentation products can be taken out of the apparatus system, and by further concentrating, distilling and crystallizing the filtration liquid, a fermentation product having an enhanced purity can be obtained.
  • the unfiltered culture liquid containing the microorganisms or culture cells, which has been filtered and separated, is kept inside the fermentation tank 1 so that the concentration of the microorganisms in the fermentation tank can be maintained in a high level, and the culture with high productivity of a chemical product can be carried out.
  • the linear flow velocity inside the circulation line can be calculated from (flowing quantity per unit time)/(cross-sectional area of pipe).
  • a Coriolis' digital flow velocity sensor, or a non-contact electrode two-line type electromagnetic flow meter, or the like may be connected to the pipe so as to carry out the measurements. By sensing the output of such a digital flow meter, the pump 5 , the flowing-quantity control means 25 and the like can be controlled.
  • the concentration of the microorganisms or culture cells in the culture liquid in the fermentation tank 1 is preferably maintained within a high level but not to cause an inappropriate state for the growth of the microorganisms or culture cells, resulting in a higher rate of deaths of those; thus, it is possible to obtain productivity with higher efficiency. For example, by maintaining the concentration at 5 g/L or more in dried weight, it is possible to obtain desired production efficiency.
  • the microorganisms or culture cells are preferably drawn from the fermentation tank.
  • the concentration of the microorganisms or culture cells inside the fermentation tank becomes too high, fouling in the separation membrane tend to be easily caused.
  • the productivity performance of a chemical product tends to be altered by the concentration of the microorganisms or culture cells in the fermentation tank, the productivity performance can be maintained within a fixed range, by drawing the microorganisms or culture cells, with the productivity performance being served as an index.
  • the supply of the culture raw material and the drawing of the culture liquid may be carried out from an appropriate point of time. That is, the starting times of the supply of the culture raw material and the drawing of the culture liquid are not necessarily made coincident with each other. Moreover, the supply of the culture raw material and the drawing of the culture liquid may be continuously or intermittently carried out.
  • the amount of culture liquid inside the fermentation tank may be preferably adjusted by using a level sensor 12 .
  • the adjustments of the amount of the culture liquid inside the fermentation tank can also be carried out not by measuring the level of the culture liquid in the fermentation tank, but by measuring the weight of the culture liquid.
  • the number of the fermentation apparatuses is not particularly limited as long as a chemical product can be generated, while microorganisms or culture cells are being grown.
  • the continuous culture operation is preferably carried out in a single fermentation tank from the viewpoint of culture managements; however, because of reasons, such as a small size of the capacity of the fermentation tank, a plurality of fermentation tanks may be used. In this case, even when continuous culture is carried out, with a plurality of fermentation tanks being connected in parallel with one another, or in series with one another, by using pipes, a resulting product can be obtained with high productivity.
  • the culture liquid refers to a liquid obtained as a result of growth of microorganisms or culture cells in the culture raw material
  • the culture raw material refers to a nutrient or the like that can accelerate the growth of microorganisms or culture cells to be cultivated, and allows a chemical product or the like that is a target product to be desirably produced.
  • the composition of the culture raw material may be changed on demand from the culture raw material composition in the initial culture time so as to make the productivity of the target chemical product higher.
  • microorganisms or culture cells to be used in the present invention examples thereof include yeast, such as bread yeast, often used industrially, bacteria, such Escherichia coli and coryneform bacteria, filamentous fungus, Actinomycetes, animal cells and insect cells.
  • yeast eukaryotic organisms, such as yeast, that easily causes cell destruction due to an inner pressure difference of a separated nucleus are preferably used, among these, yeast is more preferably used.
  • Microorganisms and culture cells to be used may be separated and isolated from the natural environment, or may be those the nature of which is partially modified by mutation or gene recombination. Among these microorganisms or culture cells, those having a high producing ability for a target chemical product are preferably selected and used.
  • the culture of microorganisms is sometimes referred to as “fermentation” or “fermentation culture”.
  • any material may be used as long as it accelerates the growth of the microorganisms or the culture cells to be cultured and can desirably produce a target chemical product.
  • Specific examples of the culture raw material include: a carbon source, a nitrogen source, inorganic salt and a general fluid-medium which contains organic trace-nutrients, such as amino acid and vitamins, on demand.
  • saccharides such as glucose, sucrose, fructose, galactose and lactose
  • starchy sugaring liquids containing these saccharides sweet potato molasses, beet sugar molasses and hi-test-molasses
  • organic acids such as acetic acid, alcohols, such as ethanol, and glycerin may be used.
  • ammonia gas, ammonia water, ammonium salts, urea, nitrate salts, and other organic nitrogen sources to be auxiliary used such as oil cakes, soybean hydrolyzation liquid, casein resolvents, other amino acids, vitamins, corn-steep-liquor, yeast or yeast extracts, meat-extracts, peptides, such as peptone, and various cultivated bacteria and hydrolysates thereof may be used.
  • the inorganic salts phosphate, magnesium salt, calcium salt, iron salt, manganese salt and so on can be appropriately added.
  • the corresponding nutritious food can be added as an authentic preparation or a natural product containing it.
  • an anti-foaming agent can be used on demand.
  • the saccharide concentration in the culture liquid is preferably maintained to 5 g/l or less.
  • the reason why to maintain the saccharide concentration to 5 g/l or less is desirable is to reduce the amount of saccharides that are washed away due to the drawing of the culture liquid to a minimum.
  • the culture of microorganisms or culture cells is carried out in a range of pH 4 to 8 at a temperature from 20 to 50° C.
  • the pH of the culture liquid can be adjusted to a predetermined value within the above-mentioned range by using materials, such as an inorganic acid or an organic acid, an alkaline material, urea, calcium carbonate and an ammonia gas.
  • materials such as an inorganic acid or an organic acid, an alkaline material, urea, calcium carbonate and an ammonia gas.
  • means such as to keep an oxygen concentration to 21% or more by adding oxygen to air, to pressurize the inside of the fermentation reaction tank, to increase stirring speed, and to increase a draft quantity, may be used.
  • continuous culture may be started; or bacteria having a high concentration may be seeded, and a continuous culture may be carried out upon starting the culture.
  • the chemical products (fermentation products) to be produced by the present invention not particularly limited as long as they are substances that are produced by the microorganisms or culture cells in the culture liquid, they can be selected on demand depending on the microorganisms of culture cells to be cultivated. Specific examples thereof include substances, such as alcohol, organic acid, amino acid, nucleic acid and the like, that are mass produced in the fermentation industries.
  • examples of the alcohol include: ethanol, 1,3-propanediol, 1,4-butanediol and glycerol
  • examples of the organic acid include: acetic acid, lactic acid, pyruvic acid, succinic acid, malic acid, itaconic acid and citric acid
  • examples of the nucleic acid include: nucleosides, such as inosine and guanosine, nucleotides, such as inosinic acid and guanylic acid, or diamine compounds, such as cadaverine.
  • the present invention can be applied to production of substances, such as enzyme, antibiotic and recombination protein.
  • lactic acid bacteria can be desirably used as the microorganism or culture cells that can be used upon producing lactic acid by the present invention.
  • the lactic acid bacteria mentioned here is defined as the prokaryotic microorganism which produces lactic acid of 50% or more in sugar-related yield to the consumed glucose.
  • Examples of the desirable lactic acid bacteria include any one of the genus of LactoBacillus, Pediococcus, Tetragenococcus, Carnobacterium, Vagococcus, Leuconostoc, Oenococcus, Atopobium, Streptococcus, Enterococcus, Lactococcus, and Bacillus.
  • the production of lactic acid can be desirably carried out.
  • the lactic acid bacteria those having a high sugar-related yield to L-lactic acid as lactic acids may be selected.
  • the L-lactic acid is one kind of optical isomers of lactic acid, and clearly distinguished from the D-lactic acid forming an enanitomer thereto.
  • Examples of the lactic acid bacteria having a high sugar-related yield to L-lactic acid include: LactoBacillus yamanashiensis, LactoBacillus animalis, LactoBacillus agilis, LactoBacillus aviaries, LactoBacillus casei, LactoBacillus delbruekii, LactoBacillus paracasei, LactoBacillus rhamnosus, LactoBacillus ruminis, LactoBacillus salivarius, LactoBacillus sharpeae, Pediococcus dextrinicus, LactoBacillus lactis, and so on, and selection can be made among these so as to be used for the production of L-lactic acid.
  • microorganisms or culture cells to be applicable to the production for D-lactic acid for example, LactoBacillus delbruekii, LactoBacillus plantarum, Pediococcus acidilactici, SporoLactoBacillus laevolacticus, SporoLactoBacillus inulinus, and so on, may be used.
  • microorganisms or culture cells to which a lactic-acid producing ability is artificially added or in which such an activity is enhanced may be used.
  • a known method by the use of drug mutation may be used; however, preferably, a recombinant microorganism is used.
  • those recombinant microorganisms in which the L-lactic acid or D-lactic acid producing ability is added to the microorganisms or culture cells, or enhanced therein, by introducing an L-lactic acid dehydrogenase gene (hereinafter, referred to sometimes as L-LDH) or a D-lactic acid dehydrogenase gene (hereinafter, referred to sometimes as D-DLH) thereto, are preferably used.
  • L-LDH L-lactic acid dehydrogenase gene
  • D-DLH D-lactic acid dehydrogenase gene
  • Escherichia coli which are prokaryotic cells, lactic acid bacteria and yeast, which are eukaryote, may be preferably used, and in particular, yeast is more preferably used.
  • yeasts preferably, those belonging to a Saccharomyces genus are used, and more preferably, Saccharomyces cerevisiae may be used.
  • L-LDH or D-LDH not particularly limited, those having an L-lactic acid dehydrogenase or a D-lactic acid hehydrogenase, which is a protein having such an activation as to convert deoxidization type nicotinamide adenine dinucleotide (NADH) and a pyruvic acid into oxidation type nicotinamide adenine dinucleotide (NAD+) and L-lactic acid or D-LDH, coded therein may be desirably used.
  • L-LDH an L-LDH derived from the Homo sapiens or an L-LDH derived from the frog origin can be desirably used.
  • an L-LDH derived from the frog belonging to Surinam toad (Pipidae) is desirably used, and among them, an L-LDH derived from an Xenopus laevis is more desirably used.
  • a gene, derived from LactoBacillus plantarum or Pediococcus acidilactici or Bacillus laevolacticus is desirably used, and more preferably, a gene derived from Bacillus laevolacticus is used.
  • the gene of a genetic-polymorphism type and the gene of a mutagenesis type caused by mutation induction are included in L-LDH or D-LDH to be used in the present invention.
  • the gene of the genetic-polymorphism type refers to those in which one portion of the base sequence of a gene is altered because of a natural mutation on the gene.
  • the mutation induction refers to a process in which a mutation is artificially induced to a gene.
  • the mutation induction is carried out by using a method in which a kit (Mutan-K, manufactured by the TAKARA BIO Inc.) for a site-directed mutation introduction is used, or a method in which a kit (BD Diversify PCR Random Mutagenesis, manufactured by (CLONTECH Inc.)) for a random mutation introduction is used.
  • a kit Metan-K, manufactured by the TAKARA BIO Inc.
  • BD Diversify PCR Random Mutagenesis manufactured by (CLONTECH Inc.)
  • the L-LDH or D-LDH to be used in the present invention even the one having a deficiency or an insertion in one portion of the base sequence can be used as long as it codes the protein having an L-lactate dehydrogenase activity or a D-lactate dehydrogenase activity.
  • the separation and purification of the L-lactic acid contained in a filtration liquid obtained from the separation membrane 3 can be carried out by combining conventionally known concentration, distillation, crystallization and so on.
  • a method in which, after the pH of the filtration liquid of the separation membrane 3 has been set to 1 or less, the resulting liquid is extracted by using diethyl ether, ethyl acetate and so on, or a method in which, after having been adsorbed onto an ion exchange resin and having been washed, elution is carried out thereon, a method in which, after having been reacted with alcohol in the presence of an acid catalyst, the resulting ester is distilled, and a method in which the culture liquid is crystallized and precipitated as a calcium salt or a lithium salt are proposed.
  • a method in which a concentrated L-lactic acid liquid obtained by evaporating moisture of the filtration liquid of the separation membrane 3 is subjected to distillation is proposed.
  • the distillation is preferably carried out, while water is being supplied so as to keep the moisture concentration of a distillation source liquid constant.
  • the resulting liquid is concentrated by heating and evaporating the moisture thereof so that a purified L-lactic acid having a target concentration can be obtained.
  • the low-boiling-point component is removed by the L-lactic acid concentration process.
  • the distillate is subjected to the removal of an impurity by using an ion exchange resin, activated carbon, a chromatographic separation or the like so that an L-lactic acid having higher purity can be obtained.
  • the separation and purification of the D-lactic acid contained in a filtration liquid obtained from the separation membrane 3 can be carried out by combining conventionally known concentration, distillation, crystallization and so on.
  • a method in which, after the pH of the filtration liquid of the separation membrane 3 has been set to 1 or less, the resulting liquid is extracted by using diethyl ether, ethyl acetate and so on, or a method in which, after having been adsorbed onto an ion exchange resin and having been washed, elution is carried out thereon, a method in which, after having been reacted with alcohol in the presence of an acid catalyst, the resulting ester is distilled, and a method in which the culture liquid is crystallized and precipitated as calcium salt or lithium salt are proposed.
  • a method in which a concentrated D-lactic acid liquid obtained by evaporating moisture of the filtration liquid of the separation membrane 3 is subjected to distillation is proposed.
  • the distillation is preferably carried out, while water is being supplied so as to keep the moisture concentration of the distilling source liquid constant.
  • the resulting liquid is concentrated by heating and evaporating the moisture thereof so that a purified D-lactic acid having a target concentration can be obtained.
  • a D-lactic acid aqueous solution having a low-boiling-point component such as ethanol and acetic acid
  • the low-boiling-point component is removed by the D-lactic acid concentration process.
  • the distillate is subjected to the removal of an impurity by using an ion exchange resin, activated carbon, a chromatographic separation or the like so that a D-lactic acid having higher purity can be obtained.
  • yeasts belonging to any one of the genus of Saccharomyces, Kluyveromyces and SchizoSaccharomyces may be preferably used.
  • Saccharomyces cerevisiae, Kluyveromyces lactis, and SchizoSaccharomyces pombe can be suitably used.
  • the bacteria which belong to the LactoBacillus genus or Zymomonas genus can also be desirably used.
  • LactoBacillus brevis or Zymomonas mobilis can be used desirably.
  • the microorganisms or culture cells that can be used for producing ethanol may be microorganisms or culture cells to which an ethanol producing ability is artificially improved. More specifically, those having one portion of the nature partially modified by mutation or gene recombination may be used. One example of those having one portion of the nature modified is given as yeast in which a glucoamylase gene of a mold that belongs to Rhizopus genus is combined so as to acquire the utilizing ability of raw starch (the microorganism, 3:555-564(1987).
  • a purification method using a distillation method for example, a concentration and purification method using an NF membrane or a RO membrane or a separation membrane made of zeolite can be desirably used.
  • microorganisms or culture cells to be used upon producing a pyruvic acid by the present invention although not particularly limited, for example, bacteria belonging to any one of the genus of Pseudomonas, Coryncbacterium, Escherichia and Acinetobacter can be desirably used. More desirably, bacteria of Pseudomonas fuluorescens, Pseudomonas aeruginosa, Escherichia coli and so on can also be used.
  • microorganisms or culture cells that can be used for producing pyruvic acid
  • microorganisms or culture cells to which a pyruvic-acid producing ability is artificially improved may be used, or those the nature of which is partially modified by mutation or gene recombination may be used.
  • those bacteria whose ATPase gene directly relating to ATP production by the oxidative phosphorylation is muted or removed can be desirably used.
  • molds, yeasts and so on may be used desirably.
  • those molds or yeasts belonging to any one of the genus of Saccharomyces, Toluropusis, Candida and Schizophyllum can be used.
  • the pyruvic acid can be produced by using molds or yeasts of Saccharomyces cerevisiae, Saccharomyces copsis, Candida glabrata, Candida lipolytica, Toluropusis glabrata, Schizophyllum commune and so on.
  • the separation and purification for a pyruvic acid contained in the filtration liquid obtained from the separation membrane 3 can be carried out by using a method in which an anion exchange column is used.
  • a purification method which uses a weak salt ion exchanger, represented by JP-A No. 6-345683, can be desirably used.
  • microorganisms or culture cells to be used upon producing a succinic acid by the present invention although not particularly limited, for example, bacteria belonging to an Anaerobiospirillum genus and an ActinoBacillus genus can be desirably used.
  • bacteria belonging to an Anaerobiospirillum genus and an ActinoBacillus genus can be desirably used.
  • Anaerobiospirillum succiniproducens described in the specification of U.S. Pat. No. 5,143,833
  • ActinoBacillus succinogenes disclosed by James B. Mckinlay et al, are proposed (applied Microbiol. Biotechnol., 71,6651-6656 (2005)).
  • coryneform bacteria belonging to the genus of Corynebacterium, Brevibacterium and Escherichia coli and so on may be utilized.
  • coryneform bacteria Corynebacterium glutamicum, Brevibacterium flavum, Brevibacterium lactofermentum, and so on are desirably used.
  • microorganisms or culture cells that can be used for producing succinic acid
  • microorganisms or culture cells to which an ethanol producing ability is artificially improved may be used. More specifically, for example, a microorganism having an improved succinic acid producing ability by gene recombination may be used, and by using this, the productivity of succinic acid can be improved.
  • a microorganism for example, Brevibacterium flavum MJ233AB-41 (confidence number: FERM BP-1498) having a deficiency of lactate dehydrogenase, disclosed in JP-A No.
  • the separation and purification for a succinic acid contained in the filtration liquid obtained from the separation membrane 3 can be carried out by a normal purification method for a succinic acid.
  • a purification method in which a water decomposition electrodialysis process and vacuum-concentration and crystallization are combined with each other, described in JP-A No. 2005-333886, is desirably used.
  • molds or yeasts are desirably used as the microorganism or culture cells that can be used for producing itaconic acid. More preferably, a producing process for an itaconic acid by using molds belonging to the genus of Aspergillus or Ustilago, or yeasts belonging to the genus of Candida or Rhodotorula, is proposed.
  • molds such as Aspergillus terreus, Aspergillus itaconicus, Ustilago maydis, Ustilago cynodontis, and Ustilago rabenhorstina, or Candia antarctica can be desirably used for the production of an itaconic acid.
  • the separation and purification for an itaconic acid contained in the filtration liquid obtained from the separation membrane 3 is preferably carried out by using ultra-filtration and electrodialysis.
  • the ultra-filtration which is described in JP-B No. 50958, or a purification method by electrodialysis in which a salt-type cation exchange resin membrane is used can be proposed.
  • microorganisms or culture cells to be used upon producing 1,3-propanediol by the present invention although not particularly limited, as native strains, specific microorganisms include those belonging to the genus Klebsiella, Clostridium, or LactoBacillus, which have an activity of synthesizing 1,3-propanediol from glycerol.
  • the microorganism Upon producing 1,3-propanediol from glycerol, the microorganism preferably includes (a) at least one gene that codes polypeptide having a glycerol hydratase activity; (b) at least one gene that codes a glycerol hydratase reactivating factor; and (c) at least one gene that codes a non-specific catalyst activity for converting 3-hydroxy propionaldehyde into 1,3-propanediol.
  • the recombinant microorganism capable of producing 1,3-propanediol from glucose is preferably used.
  • those recombinant microorganisms selected from the group consisting of: Klebsiella genus, Clostridium genus, LactoBacillus genus, Cytrobacter genus, Enterobacter genus, Aerobacter genus, Aspergillus genus, Saccharomyces genus, SchizoSaccharomyces genus, ZygoSaccharomyces genus, Pichia genus, Kluyveromyces genus, Candida genus, Hansenula genus, Debaryomyces genus, Mucor genus, Torulopsis genus, Methylobacter genus, Salmonella genus, Bacillus genus, Aerobacter genus, Streptomyces genus, Escherici
  • the recombinant microorganism capable of producing 1,3-propanediol from glucose is preferably prepared as a recombinant microorganism containing: (a) at least one gene that codes polypeptide having a glycerol-3-phosphate dehydrogenase activity; and (b) at least one gene that codes polypeptide having a glycorol-3-phosphatase activity. More specifically, the recombinant microorganism preferably includes a gene in which the glycerol dehydratase reactivating factor is coded by orfX and orfZ isolated from dha regulon.
  • the recombinant microorganism is preferably prepared as a recombinant microorganism that is deficient in a glycerol kinase activity and/or a glycerol dehydrogenase activity and/or a triosephosphate isomerase activity.
  • the separation and purification of 1,3-propanediol contained in the filtration liquid obtained from the separation membrane 3 can be carried out by concentration and crystallization.
  • concentration and crystallization For example, a purification method using vacuum-concentration and crystallization, as shown in JP-A No. 35785, is desirably used.
  • microorganism or culture cells to be used upon producing cadaverine by the present invention although not particularly limited, as a specific example, those microorganisms in which enzyme activities of lysine decarboxylase and/or lysine-cadaverine antiporter, possessed by the microorganism, are enhanced are preferably used. More desirably, the recombinant microorganism, to which a gene encoding lysine decarboxylase and/or lysine-cadaverine antiporter is inserted, is proposed. Most desirably, the recombinant microorganism, to which one or two or more kinds of genes encoding lysine decarboxylase is inserted, is proposed.
  • a recombinant microorganism having Eschericia coli or Coryneform bacteria as a host is preferably used. More preferably, Coryneform bacteria that have a lysine decarboxylase activity and also have at least any one of homoserine auxotrophy and S-(2-aminoethyl)-L-cysteine tolerance are used.
  • Coryneform bacteria those selected from a Cornynebacterium genus or Brevibacterium genus are more preferably used, and Corynebacterium glutamicum is most preferably used.
  • the microorganism preferably has a deficiency of a homoserine dehydrogenase activity, and the deficiency of a homoserine dehydrogenase activity is preferably caused by a mutation generation due to a gene insertion.
  • the separation and purification of cadaverine contained in the filtration liquid obtained from the separation membrane 3 can be carried out by combining known methods such as concentration, distillation and crystallization.
  • a purification method using crystallization as shown in JP-A No. 2004-222569, may be preferably used.
  • various polymer materials are prepared depending on acids to be used upon continuous fermentation, and in the case where the application of a polymer material in which a high purity is required, the purification method using crystallization is preferably used.
  • the pH of the culture liquid is maintained by using hydrochloric acid, cadaverine dihydrochloride can be recovered by crystallization of the filtration liquid.
  • the carboxylic acid is preferably prepared as an aliphatic and/or aromatic dicarboxylic acid having only two carboxyl groups as functional group, and any one of acids, selected from the group consisting of: adipic acid, sebacic acid, 1,12-dodecane dicarboxylic acid, succinic acid, isophthalic acid and terephthalic acid, is more preferably used.
  • microorganisms or culture cells to be used upon producing a nucleic acid by the present invention not particularly limited, those having a high producing ability of the nucleic acid may be isolated from the natural field, or the prokaryotic microorganism whose producing ability is artificially enhanced may be used. More specifically, those the nature of which is partially modified by mutation and gene recombination may be used.
  • the microorganisms and culture cells upon producing inosine, are desirably designed to have no adenylosuccinate synthetase activity or only a weak activity thereof. Moreover, they are also designed to have no inosinic acid dehydrogenase activity or only a weak activity thereof. Furthermore, they are also designed to have no nucleosidase activity or only a weak activity thereof.
  • the microorganisms and culture cells are desirably designed to have no adenylosuccinate synthetase activity or only a weak activity thereof. Moreover, they are also designed to have no guanylate reductase activity or only a weak activity thereof.
  • the microorganisms and culture cells are desirably designed to have no uridine phosphorylase activity or only a weak activity thereof.
  • cytidine they are desirably designed to have no cytidine deaminase activity or only a weak activity thereof, and also to have no homoserine dehydrogenase or only a weak activity thereof.
  • coryneform bacteria or Bacillus subtilis can be preferably used.
  • bacteria belonging to a Corynebacterium genus are used.
  • Corynebacterium genus Corynebacterium gulutamicum, Corynebacterium ammoniagenes, Corynebacterium guanofaciens or Corynebacterium petrophilium is preferably used.
  • Bacillus subtilis bacteria belonging to a Bacillus genus are proposed, and among these, Bacillus subtilis, Bacillus liqueniformis and Bacillus pumilus are preferably used.
  • Bacillus subtilis bacteria belonging to a Bacillus genus are proposed, and among these, Bacillus subtilis, Bacillus liqueniformis and Bacillus pumilus are preferably used.
  • Coryneform bacteria bacteria belonging to a Corynebacterium genus are used, and among these, Corynebacterium gulutamicum is preferably used;
  • Bacillus subtilis bacteria belonging to a Bacillus genus are proposed, and among these, Bacillus subtilis, Bacillus liqueniformis and Bacillus pumilus are preferably used.
  • Coryneform bacteria bacteria belonging to a Corynebacterium genus are used, and among these, Corynebacterium gulutamicum is preferably used.
  • uridine or cytidine among the Bacillus subtilis, bacteria belonging to a Bacillus genus are preferably used, and among these, Bacillus subtilis is preferably used.
  • the separation and purification of a nucleic acid contained in the filtration liquid obtained from the separation membrane 3 can be preferably carried out by combining known methods, such as an ion exchange resin processing method, a concentration cooling crystallization method, a membrane separation method, and the like, with one another.
  • purification may be carried out by using the known activated carbon adsorption method and recombination method.
  • amino acid Upon producing amino acid by the present invention, as the corresponding amino acid, preferable examples thereof include: L-threonine, L-lysine, L-glutamic acid, L-tryptophan, L-isoleucine, L-glutamine, L-arginine, L-alanine, L-histidine, L-proline, L-phenylalanine, L-aspartic acid, L-thyrosin, methionine, serine, valine and leucine.
  • bacteria belonging to the genus Escherichia, Providencia genus, Corynebacterium, Brevibacterium or Serratia can be used.
  • preferable bacteria include: Escherichia coli, Providencia rettgeri, Corynebacterium glutamicum, Brevibacterium flavum, Brevibacterium lactofermentum and Serratia marcescens.
  • Corynebacterium gulutamicum, Brevibacterium flavum, or Brevibacterium lactofermentum are preferably used.
  • Corynebacterium gulutamicum Brevibacterium flavum, Brevibacterium lactofermentum, Bacillus subtilis, Bacillus amyloliquefaciens and Escherichia coli can be preferably used.
  • microorganisms or culture cells to be used upon producing L-isoleucine Corynebacterium gulutamicum, Brevibacterium flavum, Brevibacterium lactofermentum or Serratia marcescens can be preferably used.
  • Corynebacterium gulutamicum As the microorganisms or culture cells to be used upon producing L-glutamine, Corynebacterium gulutamicum, Brevibacterium flavum, Brevibacterium lactofermentum or Flavobacterium rigense can be preferably used.
  • microorganisms or culture cells to be used upon producing L-arginine Corynebacterium gulutamicum, Brevibacterium flavum, Serratia marcescens, Escherichia coli or Bacillus subtilis can be preferably used.
  • Brevibacterium flavum or Arthrobacter oxydans can be preferably used as the microorganisms or culture cells to be used upon producing L-alanine.
  • Corynebacterium gulutamicum As the microorganisms or culture cells to be used upon producing L-histidine, Corynebacterium gulutamicum, Brevibacterium flavum, Brevibacterium ammoniagenes, Serratia marcescens, Escherichia coli, Bacillus subtilis or Streptomyces coelicolor can be preferably used.
  • microorganisms or culture cells to be used upon producing L-proline Corynebacterium gulutamicum, Kurthia catenaforma, Serratia marcescens or Escherichia coli can be preferably used.
  • Corynebacterium gulutamicum, Brevibacterium flavum, Brevibacterium lactofermentum or Escherichia coli can be preferably used.
  • microorganisms or culture cells to be used upon producing L-aspartic acid Brevibacterium flavum, Bacillus megatherium, Escherichia coli or Pseudomonas fluorescens can be preferably used.
  • Corynebacterium gulutamicum is preferably used as the microorganisms or culture cells to be used upon producing methionine.
  • Corynebacterium gulutamicum As the microorganisms or culture cells to be used upon producing serine, Corynebacterium gulutamicum, Brevibacterium flavum, Brevibacterium lactofermentum or Arthrobacter oxydans can be preferably used.
  • Brevibacterium lactofermentum As the microorganisms or culture cells to be used upon producing valine, Brevibacterium lactofermentum, Serratia marcescens or Klebsiella pneumoniae can be preferably used.
  • Corynebacterium gulutamicum As the microorganisms or culture cells to be used upon producing leucine, Corynebacterium gulutamicum, Brevibacterium lactofermentum or Serratia marcescens can be preferably used.
  • microorganisms or culture cells to be used upon producing the above-described amino acids those originally having a high producing ability of the amino acid may be isolated from the natural field, or the microorganisms or culture cells prepared by artificially enhancing the producing ability of the above-exemplified microorganisms or culture cells may be used. Moreover, those the nature of which is partially modified by mutation and gene recombination may be used.
  • porous membrane As the porous membrane, a porous membrane that uses an inorganic material such as ceramics, or an organic material such as a resin, as a material, may be used, and a porous separation membrane containing a porous resin layer is preferably used.
  • This porous membrane has a structure in which a porous resin layer serving as a separation functional layer is formed on the surface of a porous base material.
  • the porous base material is used for supporting the porous resin layer so as to apply strength to the separation membrane.
  • the porous resin layer may or may not permeate the porous base material; however, from the viewpoint of strength, the membrane having the porous resin layer permeating the porous base material is preferably adopted.
  • the material for the porous base material is prepared as an organic material and/or an inorganic material, and among these, an organic fiber is preferably used.
  • Preferable porous base materials are composed of fabric, non-woven fabric or the like formed by using organic fibers, such as cellulose fibers, cellulose triacetate fibers, polyester fibers, polypropylene fibers and polyethylene fibers.
  • organic fibers such as cellulose fibers, cellulose triacetate fibers, polyester fibers, polypropylene fibers and polyethylene fibers.
  • non-woven fabric which is easily controlled in its density and can be easily manufactured, is preferably used.
  • the porous resin layer functions as a separation functional layer as described above, and an organic polymer membrane is preferably used for this layer.
  • the material for the organic polymer membrane include: polyethylene-based resin, polypropylene-based resin, polyvinyl chloride-based resin, polyvinylidene fluoride-based resin, polysulfone-based resin, polyether sulfone-based resin, polyacrylonitrile-based resin, polyolefin-based resin, cellulose-based resin and cellulose triacetate-based resin.
  • the organic polymer membrane may be formed by a mixture mainly composed of these resins.
  • the main component refers to a component that is contained at 50% by weight or more, preferably at 60% by weight or more.
  • polyvinyl chloride-based resin polyvinylidene fluoride-based resin
  • polysulfone-based resin polyether sulfone-based resin
  • polyacrylonitrile-based resin or polyolefin-based resin
  • polyvinylidene fluoride-based resin or polyolefin-based resin is more preferably used, and the polyvinylidene fluoride-based resin or a resin mainly composed of this is most preferably used.
  • polyvinylidene fluoride-based resin a homopolymer of vinylidene fluoride is preferably used, and a copolymer of a vinyl-based monomer copolymerizable with vinylidene fluoride may also be preferably used.
  • vinyl-based monomer copolymerizable with vinylidene fluoride examples thereof include: tetrafluoroethylene, hexafluoropropylene, and ethylene fluoride trichloride.
  • polyolefin-based resin polyethylene, polypropylene, chlorinated polyethylene and chlorinated polypropylene are proposed, and chlorinated polyethylene is preferably used.
  • the flat membrane is obtained by processes in which, after a coat film of a film-forming stock solution containing a resin and a solvent that form a porous resin layer has been formed on the surface of a porous base material, with the porous base material being impregnated with the film-forming stock solution, only the surface on the coat film side of the porous base material is made in contact with a solidifying bath containing a non-solvent so as to solidify the resin so that a porous resin layer is formed on the surface of the porous base material.
  • the average thickness of the porous base material which is selected depending on the purpose thereof, is preferably set to 50 ⁇ m or more to 3000 ⁇ m or less, and the average thickness of the porous base material is more preferably set to 20 ⁇ m or more to 5000 ⁇ m or less, most preferably, in a range from 50 ⁇ m or more to 2000 ⁇ m or less.
  • the hollow fiber membrane is formed by processes in which a film-forming stock solution composed of a resin and a solvent that form a porous resin layer is discharged from a pipe outside of a double-pipe-type mouth piece, with a fluid for forming a hollow portion being discharged from a pipe inside of the double-pipe-type mouth piece, and this is cooled and solidified in a cooling bath.
  • the inner diameter of the hollow fiber is preferably set in a range from 200 ⁇ m or more to 5000 ⁇ m or less
  • the film thickness of the porous resin layer is preferably set in a range from 20 ⁇ m or more to 2000 ⁇ m or less.
  • a textile or a knitted cloth having a tube shape, formed by an organic fiber or an inorganic fiber may be contained inside the hollow fiber.
  • the outside surface of the hollow fiber membrane thus obtained may be coated (laminated) with another porous resin layer.
  • Such lamination of the porous resin layer may be carried out so as to modify the characteristics of the hollow fiber membrane, such as hydrophilic characteristic, hydrophobic characteristic, its pore diameter or the like, into desirable characteristics.
  • the porous resin layer to be laminated on the surface can be formed through processes in which a stock solution, formed by dissolving a resin into a solvent, is made in contact with a solidifying bath containing a non-solvent to solidify the resin.
  • a stock solution formed by dissolving a resin into a solvent
  • a solidifying bath containing a non-solvent to solidify the resin As the material for the resin to be laminated, for example, the same material as that of the porous resin layer is preferably used.
  • the lamination method may be carried out by immersing the hollow fiber membrane in the stock solution, or may be carried out by applying the stock solution onto the surface of the hollow fiber membrane, and after the lamination, one portion of the stock solution may be scraped, or blown off by using an air knife so that the amount of lamination can be adjusted.
  • the porous membrane to be used in the present invention is preferably designed to have an average pore diameter in a range from 0.01 ⁇ m or more to 1 ⁇ m or less.
  • the average pore diameter of the porous membrane is in the range from 0.01 ⁇ m or more to 1 ⁇ m or less, fouling due to the microorganisms used for fermentation hardly occurs so that the filtering performance can be continuously maintained for a long time.
  • the average pore diameter of the porous membrane is in the range from 0.01 ⁇ m or more to 1 ⁇ m or less, it is possible to provide a high expulsion rate that can prevent the microorganisms or culture cells from leaking, or can maintain a high water permeating property for a long time.
  • the average pore diameter of the porous membrane is preferably set to 1 ⁇ m or less. Moreover, the average pore diameter of the porous membrane is preferably set to have a size that is not too large in comparison with the size of the microorganisms or culture cells so as to prevent occurrence of problems, such as leakage of the microorganisms or culture cells, that is, a reduction of the expulsion rate.
  • the average pore diameter is preferably set to 0.4 ⁇ m or less, more preferably 0.2 ⁇ m or less.
  • the microorganisms or culture cells may tend to produce a substance other than the target chemical product, for example, proteins, polysaccharide, or the like, that are easily aggregated, or fragments of cells may tend to be generated due to deaths of the microorganisms or culture cells in the culture liquid.
  • the average pore diameter is more preferably set to 0.1 ⁇ m or less.
  • the average pore diameter of the porous membrane of the present invention is preferably set to 0.4 ⁇ m or less, more preferably 0.2 ⁇ m or less, most preferably 0.1 ⁇ m or less.
  • the average pore diameter of the porous membrane of the present invention is preferably set to 0.01 ⁇ m or more. More preferably, it is set to 0.02 ⁇ m or more, most preferably 0.04 ⁇ m or more.
  • the average pore diameter can be obtained by measuring processes in which, under a scanning-type electron microscopic observation in magnification of 10,000 times, all the diameters of pores observed within a range of 9.2 ⁇ m ⁇ 10.4 ⁇ m are measured and averaged.
  • a circle having the same area (equivalent circle) as the area possessed by each pore is found by an image processing apparatus or the like, and the diameter of the equivalent circle is defined as the diameter of the pore.
  • the separation membrane to be used in the present invention becomes better as the standard deviation ⁇ of the pore diameters is made smaller, that is, it becomes better as the distribution of the sizes of the pore diameters is narrowed.
  • the distribution of the sizes of the pore diameters is preferably narrowed so that the standard deviation is preferably set to 0.1 ⁇ m or less.
  • the standard deviation ⁇ of the pore diameters is calculated by the following (equation 5) in which, supposing that the number of pores to be observed within the range of 9.2 ⁇ m ⁇ 10.4 ⁇ m is N, with the respective diameters thus measured supposed to be X k and with the average value of the pore diameters supposed to be X(ave).
  • the permeability of the culture liquid containing a chemical product forms one of critical factors
  • the pure-water permeability coefficient of the separation membrane before use can be used as an index for permeability.
  • the pure-water permeability coefficient of the separation membrane is preferably set to 133 10 ⁇ 10 m 3 /m 2 ⁇ s ⁇ Pa or more, when calculated by using purified water having a temperature of 25° C. derived from a reverse osmosis membrane, with the amount of permeated water being measured at a head height of 1 m.
  • the pure-water permeability coefficient of the separation membrane is preferably set in a range from 2 ⁇ 10 ⁇ 9 m 3 /m 2 ⁇ s ⁇ Pa or more to 6 ⁇ 10 ⁇ 7 m 3 /m 2 ⁇ s ⁇ Pa or less, more preferably, from 2 ⁇ 10 ⁇ 9 m 3 /m 2 ⁇ s ⁇ Pa or more to 2 ⁇ 10 ⁇ 7 m 3 /m 2 ⁇ s ⁇ Pa or less.
  • the membrane surface roughness of the separation membrane to be used in the present invention forms a factor that gives influences to fouling of the separation membrane.
  • the membrane surface roughness of the separation membrane is preferably set to 0.1 ⁇ m or less.
  • the surface roughness is preferably made as small as possible.
  • the membrane surface roughness forms one of factors that allows microorganisms or culture cells adhered to the separation membrane surface to be easily peeled therefrom, by a membrane surface washing effect derived from a liquid flow by a stirring or a circulation pump.
  • the membrane surface roughness of the separation membrane is made as small as possible, and is more preferably set to 0.1 ⁇ m or less. In the case where the surface roughness is 0.1 ⁇ m or less, the microorganisms or culture cells adhered to the membrane can be easily peeled.
  • the membrane surface roughness of the porous membrane is set to 0.1 ⁇ m or less, it is possible to reduce a shearing force exerted on the membrane surface upon filtration of the microorganisms or culture cells, with the result that damages to the microorganisms or the culture cells can be suppressed. As a result, fouling of the separation membrane can be suppressed so that a stable filtration process can be carried out for a long time.
  • the membrane surface roughness refers to an average value of fluctuations on the membrane surface in a direction perpendicular to the membrane surface direction, and as described below, this can be measured by using an atomic force microscope (AFM).
  • AFM atomic force microscope
  • the membrane surface roughness d rough is calculated by the following (equation 6), based upon the height in the Z-axis direction of each of points measured by the AFM.
  • the above-mentioned separation membrane can be shaped into a desired form on demand in accordance with the shape of the membrane separation tank, and can be used.
  • a separation membrane element as shown in FIG. 3
  • a separation membrane element as shown in FIG. 4
  • the hollow fiber membrane is preferably used.
  • FIG. 3 is a schematic perspective view that explains one embodiment of a separation membrane element in which a separation membrane of the flat membrane mode is used.
  • the separation membrane element has a structure in which, on both surfaces of a supporting plate 18 having rigidity, a flow passage member 19 and a separation membrane 20 are placed in this order.
  • the supporting plate 18 is provided with a concave section 21 on each of the both surfaces.
  • the separation membrane 20 filtrates a culture liquid.
  • the flow passage member 19 is used for allowing a filtration liquid through the separation membrane 20 to efficiently flow onto the supporting plate 18 .
  • the filtration liquid containing a chemical product flowing onto the supporting plate 18 is allowed to pass through the concave section 21 of the supporting plate 18 , and taken out of the continuous fermentation apparatus through a liquid collecting pipe 22 serving as a discharging means.
  • a method utilizing a water-level pressure difference, a pump and a suction filtration by using a liquid, a gas or the like, or a method for pressurizing the inside of the apparatus system or the like can be used as a driving force for use in taking the filtration liquid out.
  • these separation membrane elements may be laminated so that the membrane area can be enlarged.
  • FIG. 4 is a schematic perspective view showing a separation membrane element using a separation membrane of the hollow fiber mode, which is mainly constituted by a supporting plate 18 , separation membranes 20 of the hollow fiber mode, an upper resin sealing layer 23 and a lower resin sealing layer 24 .
  • the separation membranes 20 which are formed into a bundle, are bonded and secured to the supporting plate 18 by the upper resin sealing layer 23 and the lower resin sealing layer 24 .
  • the hollow portion of each separation membrane 20 of the hollow fiber mode is sealed by the lower resin sealing layer 24 bonded and secured thereto so that the culture liquid is prevented from leaking
  • the hollow portion of each separation membrane 20 of the hollow fiber mode is not sealed by the upper resin sealing layer 23 , with the hollow portion being allowed to communicate with the liquid collecting pipe 22 .
  • This separation membrane element can be installed in the continuous fermentation apparatus by using the supporting plate 18 .
  • a filtration liquid that has been filtered through the separation membrane 20 is allowed to pass through the hollow portion of the hollow fiber membrane, and taken out of the continuous fermentation apparatus through the liquid collecting pipe 22 .
  • a driving force for use in taking the filtration liquid out a method utilizing a water-level pressure difference, a pump and a suction filtration by using a liquid, a gas or the like, or a method for pressurizing the inside of the apparatus system or the like can be used.
  • the membrane separation tank 2 provided with the separation membranes is desirably subjected to a high-pressure steam sterilization, and with this arrangement, it is possible to avoid the tank from contamination due to various bacteria.
  • the high-pressure steam sterilization of the present invention refers to a process by which microorganisms or culture cells that are present in the tank are sterilized by heating and pressurizing the membrane separation tank by using steam.
  • the heating and pressurizing conditions it is preferable to pressurize and heat the tank, for example, at 121.1° C. under a steam pressure of 1 atmospheric pressure, for 20 minutes or more.
  • the membrane separation tank 12 of the continuous fermentation apparatus, the separation membranes placed in the membrane separation tank 12 , and the element constituent members are preferably prepared as those members that are resistant to high-pressure steam sterilizing operations under these conditions.
  • the inside of the fermentation tank including the separation membrane element can be sterilized.
  • the inside of the fermentation tank is kept in a sterilizable condition, it is possible to avoid risk of contamination by undesired microorganisms upon continuous fermentation, and consequently to carry out the continuous fermentation in a stable manner.
  • the separation membrane and members such as the supporting plate that constitute the separation membrane element are preferably made resistant to the conditions of, for example, 121.1° C. under a steam pressure of 1 atmospheric pressure, for 20 minutes or more, which are the conditions for high-pressure steam sterilizing operations, and as long as these conditions are satisfied, the kinds of the separation membrane and element constituent members are not particularly limited.
  • the material for the separation membrane having such resistance the aforementioned materials for the porous membrane may be used.
  • element constituent members for the supporting plate or the like for example, metal, such as stainless steel and aluminum, or resins, such as polyamide-based resin, fluorine-based resin, polycarbonate-based resin, polyacetal-based resin, polybutylene terephthalate-base resin, PVDF, modified polyphenylene ether-based resin and polysulfone-based resin, may be preferably selected and used.
  • metal such as stainless steel and aluminum
  • resins such as polyamide-based resin, fluorine-based resin, polycarbonate-based resin, polyacetal-based resin, polybutylene terephthalate-base resin, PVDF, modified polyphenylene ether-based resin and polysulfone-based resin, may be preferably selected and used.
  • examples 1 to 9 and comparative examples 1 to 4 explain continuous production for a chemical product, which is carried out by using a continuous fermentation apparatus shown in any one of FIGS. 2 , 7 , 9 , and 13 to 16 , in which L-lactic acid was selected as the chemical product, a yeast (reference example 1) having an L-lactic acid producing ability was used as a microorganism or culture cells, and a porous membrane (flat membrane: reference example 2) was selected as a separation membrane.
  • example 10 and comparative example 5 explain continuous production for a chemical product, which is carried out by using a continuous fermentation apparatus shown in FIG. 2 , in which cadaverine (1,5-pentanediamine) was selected as the chemical product, a microorganism having a cadaverine producing ability was used as the microorganism or culture cells, and a porous membrane (flat membrane: reference example 2) was selected as a separation membrane.
  • cadaverine (1,5-pentanediamine
  • a microorganism having a cadaverine producing ability was used as the microorganism or culture cells
  • a porous membrane flat membrane: reference example 2
  • example 11 and comparative example 6 explain continuous production for a chemical product, which is carried out by using a continuous fermentation apparatus shown in FIG. 2 , in which L-lysine was selected as the chemical product, a microorganism having a L-lysine producing ability was used as the microorganism or culture cells, and a porous membrane (flat membrane: reference example 2) was selected as a separation membrane.
  • L-lysine was selected as the chemical product
  • a microorganism having a L-lysine producing ability was used as the microorganism or culture cells
  • a porous membrane flat membrane: reference example 2
  • a butterfly valve was used as a flowing-quantity control means 25 so that the flowing quantity and flowing pressure of a culture liquid to flow into the membrane separation tank were adjusted.
  • a yeast in which a L-ldh gene derived from Xenopus Laevis having a base sequence shown in SEQ ID NO: 1 was introduced to the downstream of a PDC 1 promoter was used as the yeast having a lactic acid producing ability.
  • the cloning of the L-ldh gene derived from the Xenopus Laevis was carried out by using a PCR method.
  • PCR a phagemid DNA, prepared in accordance with an attached protocol of a Xenopus Laevis kidney cDNA library (available from STRATAGENE Corporation) was used as a mold.
  • KOD-Plus polymerase (available from Toyobo Co., Ltd.) was used, and attached reaction buffer, dNTPmix and the like were also used.
  • a phagemid DNA adjusted in accordance with the attached protocol as described above was loaded in a reaction system of 50 ⁇ l so as to be set to 50 ng/sample, a primer was loaded therein so as to be set to 50 pmol/sample, and KOD-Plus polymerase was also loaded therein so as to be set to 1 unit/sample.
  • the reaction solution had been thermally denatured by PCR amplifier iCycler (manufactured by Bio-Rad Laboratories, Inc.) at a temperature of 94° C.
  • the resultant solution was subjected to 30 cycles of thermal denaturation at 94° C. for 30 seconds, primer annealing at 55° C. for 30 seconds, and complimentary strand-extension at 68° C. for 1 minute, and then cooled to a temperature of 4° C. Additionally, the reaction was carried out so that, to a gene amplification primer (SEQ ID NOs: 2 and 3), a Sall recognition sequence and a Notl recognition sequence were added on the 5-terminal side and the 3-terminal side, respectively.
  • SEQ ID NOs: 2 and 3 a gene amplification primer
  • a PCR amplified fragment was purified, and after its terminals had been phosphorylated by a T4 polynucleotide Kinase (available from Takara Bio Inc.), the resultant fragment was ligated with a pUC118 vector (which was cut by a restriction enzyme HincII, with the cut-off surface being subjected to a dephosphorylation treatment).
  • the ligation was carried out by using a DNA Ligation Kit Ver. 2 (available from Takara Bio Inc.).
  • the ligation solution was transformed into competent cells of Escherichia coli DH5 ⁇ (manufactured by Takara Bio Inc.), and these were scattered onto an LB plate containing 50 ⁇ g/mL of antibiotic substance, ampicillin, and cultivated overnight.
  • a plasmid DNA was collected by a mini-prep kit, and cleaved by restriction enzymes SalI and NotI so that the plasmid into which an ldh gene derived from Xenopus Laevis was inserted was selected. A series of these operations were all carried out in accordance with the attached protocol.
  • the pUC118 vector into which the L-ldh gene derived from Xenopus Laevis was inserted was cleaved by the restriction enzymes SalI and NotI so that the DNA fragment was separated by 1% agarose gel electrophoresis, and the fragment containing the L-ldh gene from Xenopus Laevis was purified by using a normal method.
  • the fragment containing the L-ldh gene was ligated with the XhoI/NotI cleaved portion of an expression vector pTRS11, shown in FIG.
  • a plasmid DNA was collected, and cleaved by restriction enzymes XhoI and NotI so that the plasmid into which the ldh gene from Xenopus Laevis was inserted was selected.
  • restriction enzymes XhoI and NotI restriction enzymes XhoI and NotI so that the plasmid into which the ldh gene from Xenopus Laevis was inserted was selected.
  • the expression vector with which the L-ldh gene from Xenopus Laevis thus formed was combined is referred to a pTRS102.
  • a 1.2 kb PCR fragment containing a TRP1 gene that serves as a yeast selection marker was amplified by PCR in which oligonucleotide (SEQ ID NOs: 6 and 7) was used as a primer set.
  • SEQ ID NOs: 6 and 7 oligonucleotide
  • a sequence shown in SEQ ID NO: 7 was designed so that a sequence corresponding to 60 by downstream from a stop codon of PDC1 gene could be added.
  • the respective DNA fragments were separated by 1% agarose gel electrophoresis, and purified by using a normal method.
  • a mixture of the 1.3 kb fragment and the 1.2 kb fragment thus obtained was used as an amplification mold, a PCR fragment of about 2.5 kb, in which the L-ldh gene from Xenopus Laevis, to the 5 terminal and 3 terminal of which the respective sequences corresponding to the upstream and downstream 60 by of PDC1 gene were added, the TDH3 terminator and the TRP1 gene were coupled to one another, was amplified by a PCR method in which oligonucleotide (SEQ ID NOs: 4 and 7) was used as a primer set.
  • SEQ ID NOs: 4 and 7 was used as a primer set.
  • the PCR fragment was separated by 1% agarose gel electrophoresis. After purification by a normal method, the resultant fragment was transformed into a yeast Saccharomyces cerevisiae NBRC10505 strain, and cultivated on a tryptophan non-application medium so that a transformed strain in which the L-ldh gene from Xenopus Laevis was introduced to the downstream of a PDC1 gene promoter on a chromosome was selected.
  • the transformed strain thus obtained was confirmed to be a yeast in which the L-ldh gene from Xenopus Laevis was introduced to the downstream of the PDC1 gene promoter on a chromosome in the following manner.
  • a genome DNA of the transformed strain was prepared by using a genome DNA extraction kit “Gentorukun” (registered trademark)(manufactured by Takara Bio Inc.), and it was confirmed that, by using this genome DNA as an amplification mold, an amplified DNA fragment of about 2.8 kb was obtained by PCR in which oligonucleotide (SEQ ID NOs: 8 and 9) was used as a primer set.
  • an amplified DNA fragment of about 2.1 kb was obtained by the above-mentioned PCR.
  • B2 strain the transformed strain in which the L-ldh gene from Xenopus Laevis is introduced to the downstream of the PDC1 gene promoter on a chromosome.
  • the sequences on the upstream side and the downstream side of the PDC1 gene can be obtained by Saccharomyces Genome Database (URL:http:/www.yeastgenome.org/).
  • yeast SW015 strain in which the pdcl gene is substituted by a TRP1 marker, with the pdc5 gene having a temperature-sensitive mutation, described in Pamphlet of International Publication WO2007/097260, was joined to B2 strain obtained as described above so that a diploid cell was obtained.
  • the diploid cell was formed into an ascus on an ascus formation medium.
  • the ascus was dissected by a micromanipulator so that monoploid cells were obtained, and the auxotrophy of each monoploid cell was examined.
  • strains having the ldh gene from Xenopus Laevis inserted into the pdcl gene locus, with the pdc5 gene being subjected to a temperature-sensitive mutation (incapable of growth at 34° C.), were selected.
  • the yeast strain thus obtained was defined as SU014 strain.
  • measurements were carried out by an HPLC method under the following conditions to confirm whether any lactic acid is contained in the supernatant fluid of a culture medium, in which transformed cells were cultivated in an SC medium (METHODS IN YEAST GENETICS 2000 EDITION, CSHL PRESS).
  • optical purity of L-lactic acid is calculated by the following equation:
  • L represents the concentration of L-lactic acid
  • D represents the concentration of D-lactic acid
  • PVDF polyvinylidene fluoride
  • DMAc N,N-dimethyl acetoamide
  • nonwoven fabric made of polyester fibers having a density of 0.48/cm 3 and a thickness of 220 ⁇ m that had been preliminarily affixed onto a glass plate, and then immediately immersed in a solidifying bath having the following composition at a temperature of 25° C. for 5 minutes so that a porous membrane, with a porous resin layer formed on the porous base material, was obtained.
  • the resultant membrane was immersed in hot water at a temperature of 80° C. three times so that DMAc was washed away, thereby obtaining a separation membrane(porous membrane).
  • the surface of the porous resin layer within a range of 9.2 ⁇ m ⁇ 10.4 ⁇ m was observed under a scanning-type electron microscope in magnification of 10,000 times, an average value of the diameters of all the pores observed was 0.1 ⁇ m.
  • the pure water filtration coefficient of the separation membrane was evaluated to obtain a value of 50 ⁇ 10 ⁇ 9 m 3 /m 2 ⁇ s ⁇ Pa.
  • the measurements of the amount of the filtered pure water were carries out by using purified water at a temperature of 25° C. derived from a reverse osmosis membrane, with a head height of 1 m.
  • the standard deviation of the pore diameters was 0.035 ⁇ m, and the membrane surface roughness was 0.06 ⁇ m.
  • the culture medium a raw sugar culture medium (60 g/L Yutosei (trade name, available from Muso Co., Ltd.), 1.5 g/L ammonium sulfate) was used. This raw sugar culture medium was subjected to a steam sterilizing treatment at high pressure (2 atmospheric pressure) at a temperature of 121° C. for 15 minutes, and used.
  • the separation membrane element member a molded product composed of stainless steel and polysulfone resin was used, and a porous flat membrane produced in reference example 2 was used as the separation membrane.
  • a diaphragm-type pump “APLS-20” manufactured by TACMINA Corporation
  • a peristaltic pump was used as a pump 5 inside the liquid transfer line 17 .
  • the driving conditions in examples were set as follows:
  • the SU014 strain was subjected to shaking culture overnight (primary pre-culture primarily carried) on a raw sugar medium of 5 ml in a test tube.
  • the culture liquid thus obtained was inoculated into a fresh raw sugar medium of 100 ml and subjected to, in a 500-ml Sakaguchi flask, shaking culture at 30° C. for 24 hours (pre-culture preliminarily carried out).
  • the resultant culture liquid was inoculated into a fresh raw sugar medium of 1000 ml, and subjected to, in a 3000-ml Sakaguchi flask, shaking culture at 30° C. for 24 hours (pre-culture).
  • This pre-culture liquid was inoculated into a lactic acid fermentation media of total 20 L of the fermentation tank 1 and the inside of the membrane separation tank, and the inside of the fermentation tank was stirred by a stirrer attached thereto, and the draft quantity was adjusted and the temperature and the pH were adjusted, and after 50 hours culture, the pump 4 was operated so that a filtration liquid containing an L-lactic acid was drawn out.
  • the pressure of the culture liquid to flow into the membrane separation tank 2 was measured once a day, and a flowing quantity control means 25 (butterfly valve) attached to the bypass line was adjusted so that the gauge pressure was set to 0.1 MPa.
  • the yeast turbidity in the fermentation tank After 250 hours culture, the yeast turbidity in the fermentation tank, the concentration of lactic acid as a product in the filtration liquid and the sugar concentration were measured, and the yield of lactic acid per sugar was also calculated. The results of these are shown in FIG. 10 and Table 1. Additionally, the lactic acid concentration was measured by the method shown in reference example 1. The yeast turbidity was measured by a photometer based upon light absorption at 600 nm. Moreover, the yield of lactic acid per sugar refers to a ratio of the weight of produced lactic acid to the weight of sugar consumed, and is calculated from the following equation 7.
  • the sugar concentration was measured by an HPLC method under the following conditions:
  • Continuous fermentation was carried out in the same manner as in example 1 except that a continuous fermentation apparatus shown in FIG. 9 was used, and the yeast turbidity and the concentration of lactic acid as a product were measured.
  • the apparatus shown in FIG. 9 had the same structure as that of the apparatus of FIG. 2 except that the bypass line 26 , the flowing quantity control means 25 and the open/close valves of the membrane separation tank 27 and 28 were not installed therein.
  • the liquid was transported for 2 hours through the pipes so as to each set the linear flow speeds in the circulation lines to 0.5, 1.5, and 2.5 cm/sec, and the amounts of accumulated bacteria that had been precipitated inside the pipes were measured.
  • the results thereof are shown in FIG. 6 . Based upon this, it can be said that, by setting the culture liquid linear speed inside the circulation lines to 2.5 cm/sec or more, it becomes possible to circulate the culture liquid, without causing bacteria to be precipitated inside the pipes.
  • Continuous fermentation was carried out in the same manner as in example 3 except that the continuous fermentation apparatus shown in FIG. 9 was used.
  • Continuous fermentation was carried out in the same manner as in example 3 except that a continuous fermentation apparatus shown in FIG. 7 was used, the output of the pump 5 was set to 5 L/min, and the output of the pump 16 was set to 10 L/min.
  • Continuous fermentation was carried out in the same manner as in example 4 except that a continuous fermentation apparatus shown in FIG. 13 was used.
  • the apparatus shown in FIG. 13 had the same structure as that of the apparatus of FIG. 7 except that the bypass line 26 , the flowing quantity control means 25 and the membrane separation valves 27 and 28 were not installed therein.
  • Continuous fermentation was carried out in the same manner as in example 3 except that a continuous fermentation apparatus shown in FIG. 14 was used.
  • the apparatus shown in FIG. 14 had the same structure as that of the apparatus shown in FIG. 2 , except that the liquid transfer line 15 was allowed to open at a position that is immersed in a culture liquid to be stored in the fermentation tank 1 .
  • Continuous fermentation was carried out in the same manner as in example 5 except that a continuous fermentation apparatus shown in FIG. 15 was used.
  • the apparatus shown in FIG. 15 had the same structure as that of the apparatus of FIG. 14 except that the bypass line 26 , the flowing quantity control means 25 and the membrane separation valves 27 and 28 were not installed therein.
  • Example 1 Example 2
  • Example 3 Example 2 Chemical Lactic Lactic Lactic Lactic Product Acid Acid Acid Acid Microorganism SU014 SU014 SU014 SU014 SU014 SU014 Apparatus FIG. 2 FIG. 9 FIG. 2 FIG. 2 FIG.
  • FIG. 13 FIG. 14 FIG. 15 Pump 4 3 L/hr 3 L/hr 3 L/hr 3 L/hr 3 L/hr Pump 5 5 L/min 10 L/min 10 L/min 10 L/min Pump 16 10 L/min 5 L/min — — Flux 0.180 m/day 0.180 m/day 0.180 m/day 0.180 m/day 0.180 m/day Recovery 0.5% or 0.50% 0.5% or 0.5% or Percentage less less less less less less less less less less less less less less less less less less less less less less less less Fermentation 100 h 250 h 70 h 100 h 250 h 70 h Time Compound 45 g/L 45 g/L — 45 g/L 45 g/L — Concentration Microorganism 75 200 — 75 200 — Concentration Yield Per 80% 80% — 80% 80% — Sugar
  • Continuous fermentation was carried out in the same manner as in example 1 except that a continuous fermentation apparatus shown in FIG. 16 was used, the continuous fermentation was carried out while adjusting the taking-out flowing quantity of the filtration liquid by the pump 4 so as to set the recovery percentage calculated from the value of a flowing quantity meter 30 to 1.5%, and that, even after 250 hours, the continuous fermentation was carried out.
  • the apparatus shown in FIG. 16 had the same structure as that of the apparatus of FIG. 2 except that the flowing quantity meter 30 was installed therein. Simultaneously, a transmembrane pressure difference, exerted on the separation membrane 3 , was measured with time, and the blocked time of the membrane due to an abrupt increase of the transmembrane pressure difference was evaluated.
  • the change of the measured transmembrane pressure difference is shown in FIG. 17 .
  • the transmembrane pressure difference was kept in a stable state, and with an operation at a recovery percentage of 1.5%, L-lactic acid was produced by the continuous fermentation stably for a long time.
  • the yeast turbidity in the fermentation tank, the concentration of lactic acid as a product in the filtration liquid, the sugar concentration and the yield of lactic acid per sugar were measured and calculated, and these results are shown in Table 2.
  • the change of the measured transmembrane pressure difference is shown in FIG. 17 .
  • the transmembrane pressure difference was kept in a stable state, and even under an operation at a recovery percentage of 3.0%, L-lactic acid was produced by the continuous fermentation stably for a long time.
  • the yeast turbidity in the fermentation tank, the concentration of lactic acid as a product in the filtration liquid, the sugar concentration and the yield of lactic acid per sugar were measured and calculated, and these results are shown in Table 2.
  • the change of the measured transmembrane pressure difference is shown in FIG. 17 .
  • the transmembrane pressure difference was kept in a stable state, and even under an operation having a recovery percentage of 9.9%, L-lactic acid was produced by the continuous fermentation stably.
  • the yeast turbidity in the fermentation tank, the concentration of lactic acid as a product in the filtration liquid, the sugar concentration and the yield of lactic acid per sugar were measured and calculated, and these results are shown in Table 2.
  • the change of the measured transmembrane pressure difference is shown in FIG. 17.
  • 100 hours after the start of the operation the transmembrane pressure difference abruptly rose to cause a block of the pores of the membrane.
  • the yeast turbidity in the fermentation tank the concentration of lactic acid as a product in the filtration liquid, the sugar concentration and the yield of lactic acid per sugar were measured and calculated, and these results are shown in Table 2.
  • the lactic acid concentration in the fermentation tank was 45 g/L.
  • the yeast turbidity, OD600 is increased to 100, and the yield of lactic acid per sugar was 80%.
  • FIG. 16 FIG. 16
  • Pump 4 Fluctuated Fluctuated Fluctuated Fluctuated Fluctuated Pump 5 5 L/min 5 L/min 5 L/min 5 L/min Pump 16 — — — — Flux Fluctuated Fluctuated Fluctuated Fluctuated Fluctuated Recovery 1.50% 3.00% 9.90% 12.00% Percentage Fermentation 1000 h 800 h 550 h 100 h Time Compound 45 g/L 45 g/L 45 g/L 45 g/L Concentration Microorganism 320 270 250 100 Concentration Yield Per 80% 80% 80% 80% 80% Sugar
  • cadaverine production medium a cadaverine production medium having a composition shown in Table 3 was used. This cadaverine production medium was subjected to a high-pressure (2 atm) steam sterilizing treatment at 121° C. for 15 minutes, and then used.
  • the separation membrane element member a molded product composed of stainless steel and a polysulfone resin was used, and as the separation membrane, the porous flat membrane, produced in reference example 2, was used.
  • a diaphragm-type pump “APLS-20” manufactured by TACMINA Corporation
  • a peristaltic pump was used as a pump 5 inside the liquid transfer line 17 .
  • the TR-CAD1 strain was subjected to shaking culture overnight (primary pre-culture primarily carried) on a cadaverine production medium to which 5 ml of kanamycin (25 ⁇ g/ml) was added in a test tube.
  • the culture liquid thus obtained was inoculated into a cadaverine production medium of 50 ml to which fresh kanamycin (25 ⁇ g/ml) was added and subjected to, in a 500-ml Sakaguchi flask, shaking culture at 30° C. for 24 hours under conditions of an amplitude of 30 cm, at 180 rpm (pre-culture preliminarily carried out).
  • the resultant culture liquid was inoculated into a fresh cadaverine production medium of 1000 ml, and subjected to, in a 3000-ml Sakaguchi flask, shaking culture at 30° C. for 24 hours (pre-culture).
  • This pre-culture liquid was inoculated into a cadaverine production media of total 20 L of the fermentation tank 1 and the inside of the membrane separation tank, and the inside of the fermentation tank was stirred by a stirrer attached thereto, and the draft quantity, the temperature and the pH were adjusted, and after 50 hours culture, the pump 4 was operated so that a filtration liquid containing cadaverine was drawn out.
  • the pressure of the culture liquid to flow into the membrane separation tank 2 was measured once a day, and the flowing quantity control means 25 (butterfly valve) attached to the bypass line 26 was adjusted so that the gauge pressure was set to 0.1 MPa.
  • the yeast turbidity in the fermentation tank After 250 hours culture, the yeast turbidity in the fermentation tank, the concentration of cadaverine as a product in the filtration liquid and the sugar concentration were measured, and the yield of cadaverine per sugar was also calculated. These results are shown in FIG. 18 and Table 4.
  • the cadaverine concentration was 3.5 g/L.
  • the Corynebacterium turbidity was measured by a photometer based upon light absorption at 600 nm.
  • the yield of cadaverine per sugar was 3%.
  • the cadaverine concentration was measured through the following method:
  • reaction solution 50 ⁇ l
  • acetonitrile 1 ml
  • acetonitrile 1 ml
  • the resultant solution was centrifuged at 10,000 rpm for 5 minutes, and its supernatant fluid (10 ⁇ l) was then subjected to an HPLC analysis.
  • Example 5 Chemical Cadaverine Cadaverine Product Microorganism TR-CAD1 TR-CAD1 Apparatus FIG. 2 FIG. 9 Pump 4 3 L/hr 3 L/hr Pump 5 5 L/min 5 L/min Pump 16 — — Flux 0.180 m/ 0.180 m/day day Recovery 1% or less 1% Percentage Fermentation 250 h 250 h Time Compound 3.5 g/L 1.2 g/L Concentration Microorganism 250 100 Concentration Yield Per 3% 1% Sugar
  • a diaphragm-type pump “APLS-20” manufactured by TACMINA Corporation
  • a peristaltic pump was used as the pump 5 inside the liquid transfer line 17 .
  • delta-HOM strain was subjected to shaking culture overnight (primary pre-culture primarily carried) on a BY medium of 5 ml (0.5% yeast extract, 0.7% meat extract, 1% heptone, 0.3% sodium chloride) in a test tube.
  • the culture liquid thus obtained was inoculated into a L-lysine production medium of 50 ml and subjected to, in a 500-ml Sakaguchi flask, shaking culture at 30° C. for 24 hours under conditions of an amplitude of 30 cm, at 180 rpm (pre-culture preliminarily carried out).
  • the resultant culture liquid was inoculated into a fresh L-lysine production medium of 1000 ml, and subjected to shaking culture, in a 3000-ml Sakaguchi flask at 30° C. for 24 hours (pre-culture).
  • This pre-culture liquid was inoculated into a L-lysine production media of total 20 L of the fermentation tank 1 and the inside of the membrane separation tank, and the inside of the fermentation tank was stirred by a stirrer attached thereto, and the draft quantity was adjusted, and the temperature and the pH were adjusted, and after 50 hours culture, the pump 4 was operated so that a filtration liquid containing L-lysine was drawn out.
  • the pressure of the culture liquid to flow into the membrane separation tank 2 was measured once a day, and the flowing quantity control means 25 (butterfly valve) attached to the bypass line 26 was adjusted so that the gauge pressure was set to 0.1 MPa.
  • the Corynebacterium turbidity in the fermentation tank After 250 hours culture, the Corynebacterium turbidity in the fermentation tank, the concentration of L-lysine as a product in the filtration liquid and the sugar concentration were measured, and the yield of L-lysine per sugar was also calculated. The results of these are shown in FIG. 21 and Table 6.
  • the L-lysine concentration was 6.0 g/L.
  • the Corynebacterium turbidity was measured by a photometer based upon light absorption at 600 nm.
  • the yield of L-lysine per sugar was 5.5%.
  • the L-lysine concentration was measured by using the same measuring method as in cadaverine concentration.
  • the present invention can be suitably applied to production of various chemical products obtained by the fermentation of microorganisms, such as alcohols, organic acids, amino acids, nucleic acids, enzymes, antibiotics, and recombination proteins.
  • Atmosphere pressure opening unit 13 Atmosphere pressure opening unit
  • Liquid transfer line return of unfiltered culture fluid to fermentation tank

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Sustainable Development (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Water Supply & Treatment (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
US13/121,727 2008-09-30 2009-09-16 Method for producing a chemical product and continuous fermentation apparatus Abandoned US20110177551A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2008252723 2008-09-30
JP2008-252724 2008-09-30
JP2008-252723 2008-09-30
JP2008252724 2008-09-30
PCT/JP2009/066119 WO2010038613A1 (ja) 2008-09-30 2009-09-16 化学品の製造方法および連続培養装置

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2009/066119 A-371-Of-International WO2010038613A1 (ja) 2008-09-30 2009-09-16 化学品の製造方法および連続培養装置

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/051,710 Division US10428358B2 (en) 2008-09-30 2016-02-24 Method of producing a chemical product

Publications (1)

Publication Number Publication Date
US20110177551A1 true US20110177551A1 (en) 2011-07-21

Family

ID=42073382

Family Applications (2)

Application Number Title Priority Date Filing Date
US13/121,727 Abandoned US20110177551A1 (en) 2008-09-30 2009-09-16 Method for producing a chemical product and continuous fermentation apparatus
US15/051,710 Expired - Fee Related US10428358B2 (en) 2008-09-30 2016-02-24 Method of producing a chemical product

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/051,710 Expired - Fee Related US10428358B2 (en) 2008-09-30 2016-02-24 Method of producing a chemical product

Country Status (11)

Country Link
US (2) US20110177551A1 (ru)
EP (1) EP2330209B1 (ru)
JP (1) JP5881135B2 (ru)
KR (1) KR20110060888A (ru)
CN (2) CN106011187A (ru)
AU (1) AU2009299152B2 (ru)
BR (1) BRPI0913137B1 (ru)
CA (1) CA2738981C (ru)
PL (1) PL2330209T3 (ru)
RU (1) RU2513694C2 (ru)
WO (1) WO2010038613A1 (ru)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150056685A1 (en) * 2011-09-01 2015-02-26 Fritz Cotta Method and Device for Feeding Gases or Gas Mixtures into a Liquid, Suspension or Emulsion in a Reactor in a Specific Manner
RU2573935C2 (ru) * 2011-08-24 2016-01-27 СиДжей ЧеилДжеданг Корпорейшн Способ выделения и очистки 1,4-диаминобутана из ферментационного раствора
WO2016210076A1 (en) * 2015-06-23 2016-12-29 Minn-Dak Farmers Cooperative Process for saponin enhanced autoloysis of yeast
US9644221B2 (en) 2012-03-30 2017-05-09 Toray Industries, Inc. Method of producing chemical by continuous fermentation and continuous fermentation apparatus
US10351839B2 (en) 2015-02-09 2019-07-16 Cj Cheiljedang Corporation Lysine decarboxylase having improved stability with a pH change, microorganism comprising a polynucleotide encoding the same, and method for producing cadaverine using the same
US10519416B2 (en) 2016-03-18 2019-12-31 Murata Manufacturing Co., Ltd. Filter for filtration of nucleated cells and filtration method using the same
US10858624B2 (en) 2017-04-26 2020-12-08 Murata Manufacturing Co., Ltd. Filter for filtering nucleated cells and filtering method using the same
US11498032B2 (en) 2017-07-03 2022-11-15 Murata Manufacturing Co., Ltd. Concentration apparatus
CN115536445A (zh) * 2022-09-07 2022-12-30 江苏太古合一环境管理有限公司 厨余垃圾制备液态有机基肥的方法、液态有机基肥及液态有机肥
US20230358651A1 (en) * 2022-05-09 2023-11-09 Robert G. Saunders Device Used for Real Time Field Sampling for DNA Extraction

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2650373B1 (en) * 2010-12-08 2018-08-15 Toray Industries, Inc. Method for producing cadaverine
JP5742327B2 (ja) * 2011-03-15 2015-07-01 東レ株式会社 連続発酵重量制御装置、連続発酵システム、連続発酵重量制御方法、および、連続発酵重量制御プログラム
KR20140116844A (ko) 2012-01-13 2014-10-06 도레이 카부시키가이샤 화학품의 제조방법
EP2708598A1 (en) * 2012-09-14 2014-03-19 Basf Se Serinol production in glycerol catabolism deficient escherichia coli strains
JP6467735B2 (ja) * 2014-07-18 2019-02-13 佐竹化学機械工業株式会社 培地抜出機能を有した往復動撹拌培養装置
KR102392596B1 (ko) 2015-06-17 2022-04-28 쇼와덴코머티리얼즈가부시끼가이샤 연마제, 연마제용 저장액 및 연마 방법
JP6682172B2 (ja) * 2017-03-03 2020-04-15 富士フイルム株式会社 細胞培養装置及び細胞培養方法
CN110832081B (zh) * 2017-06-30 2023-06-27 东丽株式会社 基于连续发酵的化学品的制造方法及制造装置
JP7150341B2 (ja) * 2017-09-13 2022-10-11 国立研究開発法人産業技術総合研究所 細胞培養装置および細胞培養方法
JP6815307B2 (ja) * 2017-11-09 2021-01-20 株式会社村田製作所 有核細胞の濾過用フィルターおよびそれを用いた濾過方法
KR101976955B1 (ko) * 2017-11-17 2019-05-09 영남대학교 산학협력단 박테리오 파지 배양 시스템
TWI724324B (zh) * 2017-12-21 2021-04-11 鼎唐能源科技股份有限公司 生產丁酸及／或其鹽類之方法
JP7087704B2 (ja) * 2018-06-13 2022-06-21 株式会社Ihi 細胞培養システム及び細胞培養方法
CN110117527A (zh) * 2019-05-15 2019-08-13 刘宝全 一种干细胞代谢废物的强化排出方法
JP2021045100A (ja) * 2019-09-20 2021-03-25 株式会社日立製作所 細胞分離装置及び細胞分離方法
GB2593223A (en) * 2020-03-20 2021-09-22 Dairy Crest Ltd Reactor
CN112063662B (zh) * 2020-09-22 2022-07-05 宁波海硕药业科技有限公司 一种l-亮氨酸的生产方法及其设备
CN114045225B (zh) * 2021-11-22 2023-03-10 广西科技师范学院 一种光滑假丝酵母sllsm3及其应用
CN114134036B (zh) * 2021-12-15 2023-03-10 徐州生物工程职业技术学院 小分子肽类药物生产设备及工艺
WO2024106442A1 (ja) * 2022-11-15 2024-05-23 旭化成メディカル株式会社 ろ過条件の評価方法及び細胞産生物の製造方法

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717552A (en) * 1968-10-18 1973-02-20 British Petroleum Co Apparatus for the cultivation and recovery of microorganisms
US5000843A (en) * 1988-10-17 1991-03-19 Snow Brand Milk Products Co., Ltd. Culture fluid concentrator
US5085997A (en) * 1983-07-27 1992-02-04 Drm, Dr. Muller Ag Method of separating yeasts from fermentation liquors
US5124257A (en) * 1988-04-26 1992-06-23 Azizian Asmik G Method for preparing l-alanine
US5143833A (en) * 1986-06-11 1992-09-01 Rathin Datta Process for the production of succinic acid by anaerobic fermentation
AT402635B (de) * 1993-10-21 1997-07-25 A Abfall Service Holding Ges M Anlage und verfahren zur mikrobiologischen anlage und verfahren zur mikrobiologischen behandlung flüssiger medien behandlung flüssiger medien
US5770435A (en) * 1995-11-02 1998-06-23 University Of Chicago Mutant E. coli strain with increased succinic acid production
US5869300A (en) * 1996-11-21 1999-02-09 Ajinomoto Co., Inc. Method for producing L-glutamic acid by continuous fermentation
US6022742A (en) * 1986-11-26 2000-02-08 Kopf; Henry B. Culture device and method
US20040259240A1 (en) * 2003-06-17 2004-12-23 Fadden Stephen J. Method and apparatus for filtration of bioreactor recombinant proteins
US20050272146A1 (en) * 2004-06-04 2005-12-08 Geoffrey Hodge Disposable bioreactor systems and methods
US20060019385A1 (en) * 1999-02-05 2006-01-26 Smith Gale E Apparatus and methods for producing and using high-density cells and products therefrom
US20070120449A1 (en) * 2004-07-01 2007-05-31 Hiroyuki Aizawa Angular velocity sensor and method for manufacturing the same
US20110111486A1 (en) * 2004-01-12 2011-05-12 Mayfair Technology Limited Liability Company d/b/a/ PendoTECH Bioreactor systems and disposable bioreactor

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU440021A1 (ru) * 1970-10-28 1975-03-15 Предприятие П/Я В-2262 Аппарат дл получени и переработки химических продуктов
JPS557095A (en) 1979-06-04 1980-01-18 Tsukuba Daigaku Production of itaconic acid
DE3005605A1 (de) * 1980-02-15 1981-10-01 Sartorius GmbH, 3400 Göttingen Verfahren und vorrichtung zur abtrennung von wirkstoffen aus einer zellsuspension
JPH0632626B2 (ja) 1989-02-20 1994-05-02 東レ株式会社 発酵法によるｌ―スレオニンの製造法
JP3243891B2 (ja) 1993-06-14 2002-01-07 東レ株式会社 ピルビン酸の精製方法
US6149824A (en) * 1996-08-22 2000-11-21 Water Refining, Inc. Continuous filtration system using single pump, venturi, and flow control valve
RU2123380C1 (ru) * 1996-10-22 1998-12-20 Ангарский электролизный химический комбинат Реактор для химических продуктов
JP2004222569A (ja) 2003-01-22 2004-08-12 Toray Ind Inc コリネ型細菌、ならびにカダベリンもしくはその塩およびそれらの製造方法
JP4469568B2 (ja) 2003-07-09 2010-05-26 三菱化学株式会社 有機酸の製造方法
JP4554277B2 (ja) 2004-05-27 2010-09-29 昭和電工株式会社 微生物によるコハク酸の製造方法
WO2007097260A1 (ja) 2006-02-24 2007-08-30 Toray Industries, Inc. 化学品の製造方法、および、連続発酵装置
WO2007120449A1 (en) * 2006-03-31 2007-10-25 Genencor International, Inc. Tangential flow filtration apparatuses, systems, and processes for the separation of compounds
JP5458481B2 (ja) 2007-02-06 2014-04-02 東レ株式会社 連続発酵によるｌ−アミノ酸の製造方法

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717552A (en) * 1968-10-18 1973-02-20 British Petroleum Co Apparatus for the cultivation and recovery of microorganisms
US5085997A (en) * 1983-07-27 1992-02-04 Drm, Dr. Muller Ag Method of separating yeasts from fermentation liquors
US5143833A (en) * 1986-06-11 1992-09-01 Rathin Datta Process for the production of succinic acid by anaerobic fermentation
US6022742A (en) * 1986-11-26 2000-02-08 Kopf; Henry B. Culture device and method
US5124257A (en) * 1988-04-26 1992-06-23 Azizian Asmik G Method for preparing l-alanine
US5000843A (en) * 1988-10-17 1991-03-19 Snow Brand Milk Products Co., Ltd. Culture fluid concentrator
AT402635B (de) * 1993-10-21 1997-07-25 A Abfall Service Holding Ges M Anlage und verfahren zur mikrobiologischen anlage und verfahren zur mikrobiologischen behandlung flüssiger medien behandlung flüssiger medien
US5770435A (en) * 1995-11-02 1998-06-23 University Of Chicago Mutant E. coli strain with increased succinic acid production
US5869300A (en) * 1996-11-21 1999-02-09 Ajinomoto Co., Inc. Method for producing L-glutamic acid by continuous fermentation
US20060019385A1 (en) * 1999-02-05 2006-01-26 Smith Gale E Apparatus and methods for producing and using high-density cells and products therefrom
US20040259240A1 (en) * 2003-06-17 2004-12-23 Fadden Stephen J. Method and apparatus for filtration of bioreactor recombinant proteins
US20110111486A1 (en) * 2004-01-12 2011-05-12 Mayfair Technology Limited Liability Company d/b/a/ PendoTECH Bioreactor systems and disposable bioreactor
US20050272146A1 (en) * 2004-06-04 2005-12-08 Geoffrey Hodge Disposable bioreactor systems and methods
US20070120449A1 (en) * 2004-07-01 2007-05-31 Hiroyuki Aizawa Angular velocity sensor and method for manufacturing the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
English Derwent abstract of AT 402635 *
English machine translation of AT 402635 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2573935C2 (ru) * 2011-08-24 2016-01-27 СиДжей ЧеилДжеданг Корпорейшн Способ выделения и очистки 1,4-диаминобутана из ферментационного раствора
US9732312B2 (en) * 2011-09-01 2017-08-15 Gicon Grossmann Ingenieur Consult Gmbh Method and device for feeding gases or gas mixtures into a liquid, suspension or emulsion in a reactor in a specific manner
US20150056685A1 (en) * 2011-09-01 2015-02-26 Fritz Cotta Method and Device for Feeding Gases or Gas Mixtures into a Liquid, Suspension or Emulsion in a Reactor in a Specific Manner
US9644221B2 (en) 2012-03-30 2017-05-09 Toray Industries, Inc. Method of producing chemical by continuous fermentation and continuous fermentation apparatus
US10351839B2 (en) 2015-02-09 2019-07-16 Cj Cheiljedang Corporation Lysine decarboxylase having improved stability with a pH change, microorganism comprising a polynucleotide encoding the same, and method for producing cadaverine using the same
RU2731511C2 (ru) * 2015-06-23 2020-09-03 Минн-Дак Фармерз Кооперэтив Способ автолиза дрожжей, усиленного сапонином
WO2016210076A1 (en) * 2015-06-23 2016-12-29 Minn-Dak Farmers Cooperative Process for saponin enhanced autoloysis of yeast
US10519416B2 (en) 2016-03-18 2019-12-31 Murata Manufacturing Co., Ltd. Filter for filtration of nucleated cells and filtration method using the same
US11485951B2 (en) 2016-03-18 2022-11-01 Murata Manufacturing Co., Ltd. Filter for filtration of nucleated cells and filtration method using the same
US10858624B2 (en) 2017-04-26 2020-12-08 Murata Manufacturing Co., Ltd. Filter for filtering nucleated cells and filtering method using the same
US12018277B2 (en) 2017-04-26 2024-06-25 Murata Manufacturing Co., Ltd. Filter for filtering nucleated cells and filtering method using the same
US11498032B2 (en) 2017-07-03 2022-11-15 Murata Manufacturing Co., Ltd. Concentration apparatus
US20230358651A1 (en) * 2022-05-09 2023-11-09 Robert G. Saunders Device Used for Real Time Field Sampling for DNA Extraction
CN115536445A (zh) * 2022-09-07 2022-12-30 江苏太古合一环境管理有限公司 厨余垃圾制备液态有机基肥的方法、液态有机基肥及液态有机肥

Also Published As

Publication number Publication date
US10428358B2 (en) 2019-10-01
EP2330209B1 (en) 2017-07-19
KR20110060888A (ko) 2011-06-08
AU2009299152B2 (en) 2015-07-16
PL2330209T3 (pl) 2017-12-29
CN102171349A (zh) 2011-08-31
AU2009299152A1 (en) 2010-04-08
CA2738981A1 (en) 2010-04-08
BRPI0913137B1 (pt) 2021-02-02
RU2513694C2 (ru) 2014-04-20
JPWO2010038613A1 (ja) 2012-03-01
JP5881135B2 (ja) 2016-03-09
CN106011187A (zh) 2016-10-12
EP2330209A4 (en) 2015-04-01
CA2738981C (en) 2018-07-31
BRPI0913137A2 (pt) 2020-08-11
US20160168601A1 (en) 2016-06-16
EP2330209A1 (en) 2011-06-08
WO2010038613A1 (ja) 2010-04-08
RU2011117359A (ru) 2012-11-10

Similar Documents

Publication Publication Date Title
US10428358B2 (en) Method of producing a chemical product
CA2638780C (en) Method of producing chemical product and continuous fermentation apparatus
JP5487617B2 (ja) 乳酸の製造方法
JP5978995B2 (ja) 連続発酵による化学品の製造方法
CN101553572A (zh) 化学品的制备方法和连续发酵装置
JP5659466B2 (ja) 連続培養による化学品の製造方法および製造装置
AU2011304167B2 (en) Production method for chemicals by continuous fermentation
JP2009142210A (ja) 連続発酵による乳酸の製造方法
JP5593594B2 (ja) 連続培養による化学品の製造方法
JP5593597B2 (ja) 乳酸の製造方法

Legal Events

Date Code Title Description
AS Assignment

Owner name: TORAY INDUSTRIES, INC., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MIMITSUKA, TAKASHI;ISHII, KENTARO;MORITA, KEN;AND OTHERS;REEL/FRAME:026046/0762

Effective date: 20110208

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION